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           10 SELECTED MEDICINAL PLANTS OF PAKISTAN 
 
 
1.  Cassia fistula (L), caesalpinaceae     
                                                                 
2. Trigonella foenum-graecum(L), leguminosae          
                          
3. Carica papaya (Linn), caricaceae        
                                                               
4. Dioscorea floribunda (M. Martens & Galeotti), dioscoreaceae        
                  
5. Citrullus colocynthis (L.) Schard , cucurbitaceae     
                                          
6. Ferula asafoetida (H. Karst.), Leguminosae      
                                                
7. Caesalpinia crista (L), caesalpinaceae      
                                                        
8. Smilax ornata (Lem.), smilaceae     
                                                                 
9. Styrax benzoin (Drynad), styraceae                                                                 
 






                             INTRODUCTION 
 
In this thesis,   I have done research to find any scientific studies, which has been done about 
these selected 10 medicinal plants of Pakistan, for the Institute of Pharmacy at The University 
of Oslo. In this thesis I have focused on the chemical, biological and toxicity studies which 
could give the scientific basis for the traditional usage of these plants. 
 
After getting traditional information about a lot of safe and effective herbal remedies in 
Pakistan, i and my instructor, at the institute of pharmacy university of Oslo, Berit Smestad 
Paulsen, chose 10 medicinal plants, which I have tried to find scientific work about. 
ISLAMIC REPUBLIC OF PAKISTAN                                 
The areas included in Islamic Republic of Pakistan, has been a part of Asia minor, having 
hundreds of thousands years old historical background. The Asia minor had been ruled over, 
by powerful and great emperors in the past.  
Pakistan got independence from the British rule on 14
th
 of august 1947 and has been a 
democratic state since then. 
 
Pakistan is full of natural beauty; greater differences are found in weather depending upon 
geographical location. There are four weathers in a year. One can easily note the climate 
variation from warmest areas where temperature raise up to 50 ◦C to coldest areas where there 
is snow fall round year. 
Capital city= Islamabad                          Number of provinces = 4 
Largest city= Karachi                          Area= 803940 square kilometer. 
Population= 172,800,000.                       Currency= Rupee 
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MEDICINAL PLANTS OF PAKISTAN 
There are great class differences in Pakistan. Great number of people makes their living 
through agriculture. All the kinds of treatments are available from smaller to bigger hospitals.  
However a lot of herbal remedies, known to the herbalist (Hakeem in the local language) and 
older wise people, mostly in the rural areas, are still being used safely and effectively by both 
the humans and livestock for various ailments. The traditional medicines are cheaper, 
especially for those living in the rural areas with lower income. However a lot of people living 
in the urban areas also believe in the traditional usage of these remedies. A few institutions 
like Hamdard laboratories has done scientific work about a lot of herbal remedies and is 
marketing a lot of quality controlled traditional herbal remedies which are both safe and 
effective. 
 
To get information about 10 most popular medicinal plants, i used the following resources 
with the help of external instructors:- 
1. Hakeem (an herbalist having authorization or knowledge about herbal remedies which 
has learned at an herbal institution or got it transferred from forefathers. 
2. Wise older people. 
3. Traditional Literature. 




 BACKGROUND LITERATURE 
Literature search was done in the following authentic scientific databases like Medline, 
Embase/ Ovid, Biological Abstracts, ISI web of knowledge, International Pharmaceutical 
Abstracts/ SciFinder. A few articles from the other languages were electronically translated 
from Japanese, German and Chinese languages to English where it was possible. 
Search for the correct plant names was done in www.Ipni.org; a worldwide recognized 
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Literature references are given in parentheses with writer‘s name and Year. The complete 
reference list is given at the end of every chapter. References from internet are given with IP 




The chemical structures where necessary are given under the chemical studies done with 







M= molar concentration 
µM= micro molar concentration 
nM= nano molar concentration 
µg= micro gram 
i.p= intraperitoneally 
p.o= per oral  
i.v= intravenous 
ED50= effective dose which gives required effect in the 50 % of population under test. 
IC50= Concentration of a substance required to kill 50 % of test organisms. 
LD50= lethal dose which causes death in 50% test population. 
mg= milli gram 
Kg= kilo gram 
ml= milli liter 
mTOR= Mammalian target of Rapamycin 
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HER2= Human epidermal growth factor Receptor 2 
JNK = c-jun N-terminal Kinases; kinases that bind and phosphorylate c-jun[ a gene which in 
combination with c-Fos( a cellular proto-oncogene belonging to the immediate early gene 
family of transcription factors)forms the activation protein-1(AP-1) early response 
transcription factor] on ser 63 and ser 73 within its transcriptional activation domain, are 
mitogen-activated protein kinases which are responsive to stress stimuli, such as cytokines, 
ultraviolet irradiation, heat shock, and osmotic shock, and are involved in T cell 




  THE WEB REFERENCE TO THE PHOTO OF Caesalpinia crista ON FRONT PAGE 
 
http://homepage3.nifty.com/inagiyasou/photo/iriomote06/jmk2/nantenkazra.jpg 















                                              





















BOTANICAL NAME: - Cassia fistula (L) 
ENGLISH NAME: - Golden Shower 
URDU/ LOCAL NAME: - Amaltas 
FAMILY: - Leguminosae 
 
 
PARTS OF PLANT USED:- 




USES IN PAKISTAN 
1. CATHARTIC 
2. ANTI-RHEUMATIC 
USES IN INDIA 
In the Indian literature Cassia fistula has been described to be of the following uses as 
reported by (Alam et al., 1990; Asolkaret al., 1992):- 
1. USEFUL AGAINST SKIN DISEASES like leucoderma and pruritis. 
2. LIVER TROUBLES, TUBERCULOSUS GLANDS 
3. TREATMENT OF WOUNDS 





  OTHER USES  
1. Mild laxative for children and women, recognized by The British pharmacopoeia 
(Bahorun, Neergheen et al. 2005). 
2. Purgative owing to containing aloin and as tonic (Satyavati and Sharma, 1989). 
3. Intestinal disorders like ulcer (Biswas et al., 1973; Kirtikar and Basu, 1975). 
4. Antipyretic and Analgesic (Patel et al., 1965). 
5. Anti-inflammatory and hypoglycemic activity (Bahorun, Neergheen et al. 2005). 
6. Inhibits Leukotriene synthesis thus contributing to anti-inflammatory effect 
 (Sunil Kumar and Müller, 1998). 
7. Antitussive and wound healing (Bhakta et al., 1998a, b). 
8. Against Hypercholesterolemia due to fiber and mucilage content in Cassia fistula as 
suggested by (El-Saadany et al., 1991), also due to presence of  
β-sitosterol. 
9. Other uses include use in diseases and pest control in India (Jaipal et al., 1983; 
Sharma and Basandrai, 1999; Raja et al., 2000). 
10. Callus cultures(derived from young leaves) of Cassia fistula could be used to produce 
a lot of valuable antioxidative and chemopreventive compounds like Flavonoids and 




The principle ingredients which are therapeutically important are 
1- Glycosides ( Sennoside A, Sennoside B), leaves are rich sources as reported by 
(Bahorun, Neergheen et al. 2005). 
 
2- Phenolic antioxidants like Anthraquinone (Bahorun, Neergheen et al. 2005). 
Major Anthraquinone was rhein (1, 8-dihydroxy-3-anthraquinone carboxylic acid) 
present in pulp as reported (by Modi and Khorana, 1952). Pods are rich in phenolic 
contents as reported by (Luximon-Ramma et al., 2002). 
3- Flavonoids(Bahorun, Neergheen et al. 2005). 
4- Flavan-3-ol derivatives(Bahorun, Neergheen et al. 2005). 
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Other ingredients having therapeutic importance include:- 
5- Wax aloin (Satyavati and Sharma, 1989).  
6- Minerals like heavy metals are also present depending upon the mineral content in the 
soil (Biswas 2006). It may be exploited both industrially to explore heavy metal 
content in a geographic area also to find environmental pollution and its potential 
effects on human health and biodiversity. 
7-  It has been reported that the stem bark of Cassia fistula is also a potential source of 
lupeol, ß-sitosterol and hexacosanol (Sen andShukia, 1968). 
 
8- The seeds are rich in glycerides with linoleic, oleic, stearic and palmitic acids as major 
fatty acids together with traces of caprylic and myristic acids, 






1. ANTIOXIDANT ACTIVITY 
Cassia fistula contains a lot of phenols i.e. Anthraquinone and flavonoids with 
proanthrocyanidine; that is why it exhibits greater antioxidant activity which is 
responsible for a lot of pharmacological activities which have therapeutic 
exploitation. Antioxidant activity of the reproductive parts like pods is higher than 
non vegetative parts (Luximon-Ramma, Bahorun et al. 2002). 
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2. ANTICARCINOGENIC ACTIVITY 
Mechanisms of anti-carcinogenic action include their binding to 
carcinogens, their ability to inhibit phase I and induce phase II carcinogen 
metabolizing enzymes and their  potential to modulate signal transduction 
pathways (Bahorun, Neergheen et al. 2005).  
They may prevent tumor development  by inducing tumor cell apoptosis by 
inhibiting DNA topoisomerase II and p53 down regulation or by causing 
mitochondrial toxicity, which initiates mitochondrial apoptosis (Galati et al., 2000; 
Birt et al., 2001; Ren et al., 2003; Galati and O‘Brian, 2004).  
Anti-tumor activity of Cassia fistula seed extract based on cytological studies 
reveal that a reduction in the mitotic activity can be the leading mechanism of 
action against tumor genesis. Indeed the appearance of membrane blebbing and 
intracytoplasmic vacuoles in the treated tumor cells suggest that these pathways 
may account for the reduction in tumor volume (Gupta et al., 2000). 
 
3. MODULATION OF HUMORAL IMMUNITY 
Synergistic effect of Cassia fistula in combination with antibiotic Amoxicillin was 
studied by (Ali Nafisa, Kazmi Shahana et al. 2008), it was found that a combination of 
Cassia fistula and amoxicillin i.e. amoxy-cassia exhibits stronger reinforcement of 
humoral immunity than amoxicillin alone, but the exact mechanism needs to be 
elucidated by further research. 
This study was done on humoral immune system of BALB/c mice. Animals were 
immunized with sheep RBC and treated with Cassia fistula fruit, amoxy-cassia, 
amoxicillin and saline. Number of activated anti-SRBC producing cell in spleen was 
calculated by haemolytic plaque assay. Antibody titer in blood was measured by 
haemagglutination test. Number of plaques formed by the animal treated with Amoxy-
cassia, amoxicillin, Cassia fistula, and normal saline were 191, 86, 53, 34 per 10(5) 
spleen cells respectively. Haemagglutinating Antibody (HA) titer was evaluated on 
post-immunized day 4, 6, 8, 10. Rising antibody titer was observed in all animals but 
Amoxy-cassia treated mice serum had the highest HA titer throughout the experiment 
suggesting its therapeutic usefulness. 
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4. LOWERING OF CHOLESTEROL CRYSTALS GROWTH 
(Ammal, George et al. 2007) studied the effect of cassia fistula on inhibition of 
cholesterol crystals growth in an in vitro study.  
The most dangerous type of cholesterol crystals present in various pathologies 
including gall stone and atherosclerotic patches is monohydrated type having plate like 
morphology.  
Monohydrated cholesterol crystals could easily be identified by examining the habits 
of it deposits (Straffer and Bischoff, 1964). 
(Ammal, George et al. 2007) studied the growth of cholesterol crystals in sodium 
metasilicate (SMS) gel medium. Experiments conducted using the extract of Cassia 
fistula as an additive clearly showed an inhibition on the crystal growth. The crystals 
formed in the control have plate like morphology. The addition of the Cassia fistula 
extract showed not only a delay in nucleation but also a change in morphology. The 
crystal growth was seen in control tubes within an hour of pouring the supernatant 
solution.  
The grown crystals were clear, transparent and plate like and grown to an average size 
of 1.6 to 1.8 cm within 2 days. But with the addition of the additive (Cassia fistula) in 
serial dilution, the appearance of the crystals changed to needle like, and then to wool 
like, in the case of maximum addition of Cassia fistula in the observed experiments. 
Length of growth of the crystals is also found to decrease with the increase in 
concentration of the Cassia fistula solution. The change in morphology is a clear 
indication of the inhibition of cholesterol crystal growth which may be attributed to 
the effect of some phytoactive compound in the Cassia fistula. Presence of Cassia 
fistula clearly indicates control of cholesterol growth, as concentration of Cassia 
fistula increases percentage growth of cholesterol reduces – also change in 
morphology, crystals are soft and the reduction in growth of cholesterol is not to zero 
so that no damage to body, no harmful effect, but very effective in controlling the 
growth. 
5. ANTIBACTERIAL EFFECT 
Cassia fistula extract has shown antibacterial activity against a wide spectrum of 
bacteria namely Escherichia Coli, Bacillus mycides, Bacillus subtilis, 
Mycobacterium smegmatis, Klebsiella aerogenes, Pseudomonas aerogenes and 
Proteus vulgaris (Perumal et al., 1998). 
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6. ANT-FUNGAL ACTIVITY 
(Duraipandiyan and Ignacimuthu 2007) demonstrated that Cassia fistula extract 
have both antibacterial and antifungal activity. 
 
Antibacterial and antifungal activity of Cassia fistula extract was demonstrated by 
(Duraipandiyan and Ignacimuthu 2007); hexane, chloroform, ethyl acetate, methanol 
and water extracts from the flower of Cassia fistula (an ethnomedicinal plant) were 
tested against bacteria and fungi. All the extracts exhibited antibacterial activity 
against Gram-positive organisms with minimum inhibitory concentrations (MIC) 
between 0.078 and 2.5 mg/ml. Among the Gram-negative bacteria, only Pseudomonas 
aeruginosa was susceptible to the extracts. Ethyl acetate crude extract was 
fractionated using chromatographic techniques. A crystal was isolated, which was 
confirmed as 4-hydroxy benzoic acid hydrate using X-ray crystallography.  
It exhibited antifungal activity against Trichophyton mentagrophytes (MIC 0.5 mg/ml) 
and Epidermophyton floccosum (MIC 0.5 mg/ml). These facts shows that the 
ingredients present in Cassia fistula extract has anti-fungal activity.  
7. LARVICIDAL AND OVICIDAL ACTIVITY 
(Govindarajan, Jebanesan et al. 2008) studied ovicidal and larvicidal activity of 
methanolic extract of Cassia fistula leaves, they found that extract was more lethal 
to the larvae of Anopheles stephensi than  
Culex quinquefasciatus with LC 50 values of 17.97 and 20.57 mg/ l, respectively. 
Mean percent hatchability of the ovicidal activity was observed 120 h after 
treatment. Mean percent hatchability was inversely proportional to the 
concentration of extract and directly proportional to the eggs. 
The egg raft of C. quinquefasciatus was found to be more hatchable than  
A. stephensi. The results show that the leaf extract of Cassia fistula is promising as 
a larvicidal and ovicidal agent against C. quinquefasciatus and A. stephensi. 
8. ANTI-LESHMANIAL ACTIVITY 
Natural products represent a rich source of new chemical entities for the 
development of drugs for neglected diseases. Leishmaniasis still afflicts the 
poorest populations in the world, with 12 million cases worldwide. (Sartorelli, 
Andrade Samanta et al. 2007) analyzed the crude extracts and fractions from the 
 33 
 
fruit of Cassia fistula against the most dramatic and fatal disease form of 
Leishmaniasis, the visceral form (VL). 
 Hexane extract from the fruits showed significant antileishmanial activity against 
the promastigote form of Leishmania L. chagasi. The bioguided fractionation 
resulted in the isolation of a sterol, clerosterol, which was further analyzed in 
different models. Promastigotes presented an inhibitory concentration (IC50) of 
10.03 µg/mL and intracellular amastigotes demonstrated higher susceptibility, with 
an (IC50) of 18.10 µg/mL. Mammalian cytotoxicity was evaluated and it was 
demonstrated that clerosterol was 3.6-fold less toxic than the standard drug 
Pentamidine. 
µg= micro gram 
 
9. HEPATIC EFFECTS 
Scientific evidence for the usage of Cassia fistula against hepatic disorders is being 
provided by the following study done by (Pradeep, Mohan et al. 2007), the 
hepatoprotective and antioxidant effect of Cassia fistula leaf extract on liver injury 
induced by diethylnitrosamine (DEN) was investigated. Wistar rats weighing 200 +- 
10 g were administered a single dose of DEN (200 mg/kg b.w., i.p.) and left for 30 
days. For hepatoprotective studies, ethanolic leaf extract (ELE) of Cassia fistula (500 
mg/kg b.w., p.o.) was administered daily for 30 days. AST, ALT, ALP, LDH, gamma 
-GT and bilirubin were estimated in serum and liver tissue. Lipid peroxidation (LPO), 
SOD and CAT were also estimated in liver tissue as markers of oxidative stress. DEN 
induced hepatotoxicity in all the treated animals were evident by elevated serum ALT, 
AST, ALP and bilirubin levels and a simultaneous fall in their levels in the liver tissue 
after 30 days. Induction of oxidative stress in the liver was evidenced by increased 
LPO and fall in the activities of SOD and CAT.  
ELE of Cassia fistula administration for 30 days prevented the DEN induced hepatic 
injury and oxidative stress. In conclusion, it was observed that ELE of Cassia fistula 








Cassia fistula plant may contain heavy metals like Cu, Co, Ni, pb, Zn, Cr, Fe, Mn, F and 
K2O, the concentration of these elements depends upon the soil mineral status as studies by 
(Biswas 2006).  
The concentrations of these elements present in ppm (part per million except K2O expressed 
in Percent), present in Cassia fistula leaves, in mineralized and non-mineralized areas is given 
below as studied by (Biswas 2006) in India:- 
 
 
 Cu Co Ni Pb Zn Cr Fe Mn F K2O% 
MA 1 2 13 3 19 6 107 99 1 0.71 
NM 0 6 15 3 18 13 78 98 0 0.74 
 MN= Mineralized area, NM= Non mineralized area 
The concentrations of Co(Cobalt), Ni(Nickel) and lead are higher, especially in the 
mineralized areas, than toxic levels according to standards given in Remington, 20
th
 edition, 
2000).The higher concentration of these heavy metals could cause serious toxicities to 
animals including human beings. The most toxic trace mineral is lead (Pb) and Nickel (Ni). 






 CATHARTIC ACTIVITY  
(Ahmed, Qureshi et al. 1989) Studied cathartic activity of the Sennoside glycosides 
from Cassia fistula using Lou, s method.  
Cassia fistula has shown  cathartic activity proving scientific evidence for 
ethnopharmacological use of Cassia fistula dried leaves as cathartic in Pakistan 
however the cathartic activity of cassia fistula is weaker than that of Cassia 
angustifolia , also the cathartic activity of the legumes is stronger than that of leaves 
depending upon the glycoside/ Sennoside content. 
 
(Bahorun, Neergheen et al. 2005) suggested the presence of antioxidants like 
anthraquinone which also have laxative effect; this fact indicates that Sennoside and 
Anthraquinone may synergize the effect of each individual substance, on the bowl 
movement. 
 
 ANTI-OXIDANT EFFECTS 
The phytochemical studies done by (Bahorun, Neergheen et al. 2005) indicates the 
presence of antioxidant phenols like Anthraquinone and Flavonoids etc , which are 
secondary metabolite products found in Cassia fistula extract, the antioxidant effect of 
these biological molecules like free radical scavenging activity and inhibition of 
oxidation of biomolecules like fats etc. may have a prophylactic use against a no. of 
fatal diseases like cancer and heart diseases. Thus Cassia fistula may be used in the 
nutritional/food supplements this fact reinforces the traditional usage of Cassia fistula 
for various types of ailments in India and Pakistan and the other parts of the world. 
 
Consequently, there has been a growing interest in the potential health-promoting 
properties of phytochemicals of plant origin. Special attention has been given to 
vitamin E, vitamin C and more particularly to phenolic derivatives including 
Anthraquinone, xanthones, phenolic acids, phenolic diterpenes, Flavonoids, catechins, 





These substances have also been reported to exhibit biological effects including 
antibacterial, anti-viral, anti-inflammatory, antithrombotic, antimutagenic, 
anticarcinogenic, antiageing and vasodilatory actions (Middleton and Kandaswami, 
1994; Bravo, 1998; Caroll et al., 1998; De Bruyne et al., 1999; Di Carlo et al., 1999; 
Duthie et al., 2000; Middleton et al., 2000; Ferguson, 2001).    
 
The following 2 studies further prove that Cassia fistula fruit has nutritional potential:- 
(Barthakur et al., 1995) reported the presence of 15.3%, 13% and 7.8% of aspartic 
acid, glutamic acid and lysine of the total amino acids respectively in the pulp. 




 MODULATION OF HUMORAL IMMUNITY 
Ali Nafisa, Kazmi Shahana et al. 2008 found that Cassia fistula augments humoral 
immune response but further detailed studies of mechanisms of immunomodulation 
and its probable use in immuno compromised individual are still to be investigated. 
These facts indicate that Amoxy-cassia may be used as an adjuvant during vaccination 
programs in order to reduce number of non-responder to vaccines. 
 ANTI-BACTERILA AND ANTI-FUNGAL EFFECTS 
(Perumal et al., 1998) studied therapeutic efficacy of Cassia fistula extract against a 
no. of bacterial species, these findings may be exploited to find alternative 
antibacterial medicines to curb the strains of bacterias resistant to the conventional 
chemotherapeutic agents. 
 
Antibacterial and antifungal activity of Cassia fistula extract was demonstrated by 
(Duraipandiyan and Ignacimuthu 2007) during the in vitro studies done in the 
laboratory. The anti-fungal effects, shown by Cassia fistula extract may lead to a 
future herbal anti-fungal drug which could effectively solve the resistance to the 
presently used drugs keeping side effects at much lower level.  
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 ANTI-LEHMENIAL EFFECTS 
Anti-leshmenial effect of Clesterol presnt in Cassia fistula studied by (Sartorelli, 
Andrade Samanta et al. 2007) this work showing lower toxicity than traditional 
medicine Pentamidine and therapeutic efficacy gives a starting point to find more 
about it. 
 
 INHIBITION OF CHOLESTEROL CRYSTALS GROWTH 
The study done by (Ammal, George et al. 2007) described, efficacy of Cassia fistula 
extract on inhibition of cholesterol growth inhibition, in a  growth experiment 
conducted using the Cassia fistula extract added to the superannuated solution of 
cholesterol. It showed that it has got an inhibitory effect on the crystallization. Crystals 
formed in the control have plate like morphology but the addition of the extract 
showed not only a delay in nucleation but also a change in morphology. The crystal 
turned from plate-like to needle-like and also with a wool-like appearance.  
The change in morphology is a clear indication of inhibition of cholesterol crystal 
growth which may be attributed to some phytoactive compound in the Cassia fistula 
extract. This fact is supported by 1R studies in which the hydroxyl bonds seen in 
control crystal were absent in the crystals grown after treatment with Cassia fistula 
extract. In oxidation of secondary alcohol to ketone, one learns to expect the 
disappearance of hydroxyl (O-H) stretch and appearance of carbonyl (C=O). X-ray 
studies proved it to be triclinic system. An addition of Cassia fistula extract in the 
growth stage can reduce the growth of cholesterol crystal i.e. additional crystallization 
of cholesterol can be avoided; this effect is significant in the pathologies caused by 
deposition of monohydrated crystals of cholesterol like atherosclerosis in the blood 






Since the morphology of the monohydrated cholesterol crystals presnt in the body is same like 
one which is studied in the study done by (Ammal, George et al. 2007), which means that 
inhibition of cholesterol crystals growth and changes in morphology are significant effects. In 
oxidation of secondary alcohol to ketone, one learns to expect the disappearance of hydroxyl 
(O-H) stretch and appearance of carbonyl (C=O). X-ray studies proved it to be triclinic 
system. An addition of CF in the growth stage can reduce the growth of cholesterol crystal i.e. 
additional crystallization of cholesterol can be avoided Therefore Cassia fistula extract is a 
suitable medicine, without side effects, for the control of cholesterol crystallization. 
 
This efficacy of Cassia fistula in inhibition of cholesterol crystals growth may be a 
milestone for the scientists trying to find substances that can replace or could be used 
concomitantly with synthetic substances to treat cerebrovascular coronary and 
peripheral vascular diseases due to deposition of cholesterol crystals in the 
atherosclerotic patches and gall stone diseases. 
 WOUND HEALING PROPERTIES 
Wound healing usage in India has been scientifically proved by  the study done by 
(Bhakta, Mukherjee et al. 1998); Cassia fistula commonly known as Sundali was 
selected to evaluate its wound healing potentials based on traditional use and literature 
refs. Methanol ext. of Cassia fistula leaves were examined for its wound healing 
property in the form of an ointment in two types of wound models in rats: 
(i) Excision wound model and 
(ii) Incision wound model. The ointment of the leaf extract of two different 
concentrations. (5% and 10% wt. /wt. ointment of leaves ext. in simple ointment base) 
responded significantly in both models of wounds tested.  
The results were also comparable to that of standard drug, nitrofurazone in terms of 
wound contraction ability, epithelization period, tensile strength and regeneration of 
tissue at wound area. 
 ANTI-CANCER EFFECTS 
Studies done by (Bahorun, Neergheen et al. 2005)demonstrates anticarcinogenic effect of  
Cassia fistula. Further it indicates that reduction in mitotic activity might be the main 
mechanism involved, thus giving starting point for further research, research also needs to 
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be undertaken to ascertain the mechanisms of DNA    protection, hence delineating the 
antimutagenic and anticarcinogenic effects of Cassia fistula extracts. 
 ANTI-RHEUMATIC 
(Biswas et al.1973; Kirtikar and Basu, 1975) studied and proved the anti-rheumatic 
effect of Cassia fistula thus reinforces and scientifically prove the traditional usage of 
Cassia fistula, in Pakistan, as anti-rheumatic agent. 
Another study done by (Sunil Kumar and Müller, 1998) shows inhibition of synthesis 
of mediators of inflammation ‖Leukotrienes‖ a mechanism involved in anti-rheumatic 
treatment also reinforces the traditional usage as anti-rheumatic in Pakistan.  
 
 HYPOGLYCEMIC EFFECTS 
(Esposito Avella, Diaz et al. 1991) studied the anti-diabetic effect of aqueous extract 
of Cassia fistula, the aqueous fraction produced a significant decrease in the glycemia 
(p <0.001) at 4 and 24 hours with doses of 300 and 500 mg/kg, and at one and four 
hours after the dose of 1000 mg/kg (p<0.001). In the glucose tolerance test, the 
aqueous fraction of Cassia fistula produced a significant decrease (p<0.05) with the 
dose of 500 mg/kg at 0.25 and 0.5 hours. The 1000 mg/kg dose produced a significant 
increase (p<0.001) at 0.25 and 2 hours. 
Rhamnetin 3-O-beta -D-glucopyranosyl-(1->6)-beta -D-glucopyranoside is the 
compound responsible for hypoglycemic effect of Cassia fistula as studied by 
(Vaishnav and Jain 2004). 
This work scientifically supports the traditional usage of Cassia fistula as 
hypoglycemic agent. Further research could design a safe and effective herbal 
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              Trigonella foenum-graecum 
        









BOTANICAL NAME:-Trigonella foenum-graecum (L) 
ENGLISH NAME: - Fenugreek 
URDU/ LOCAL NAME: - Methi 
FAMILY: - Leguminosae  
 
PARTS OF PLANT USED:- 
Dried seeds, Leaves 
DESCRIPTION 
The plant is grown as green leafy vegetable and for its seeds.  
The robust herb has light green leaves, is 30-60 cm tall, and produces slender beaked pods 
which are 10-15 cm long. Each pod contains 10-20 small hard yellowish brown seeds, which 





USES IN PAKISTAN AND INDIA 
 
USES AS FOOD 
Pakistanis and Indians also like the fresh leaves, which are eaten as a very tasty 
vegetable and prepared like spinach, or dried and used as flavoring. 





Both seed and plant are used medicinally. 
 HYPOGLYCEMIC EFFECTS 
               Fenugreek has been prescribed for diabetes mellitus by the herbalists in Pakistan and 
India. A glass of milk or water in which a tablespoon of seeds of 
 Trigonella foenum-graecum has been soaked overnight is drunk each morning. 
 CHOLESTEROL LOWERING EFFECT 
 FOR GASTROINTESTINAL DISEASES 
● ANTI-ULCER 
Trigonella foenum-graecum seeds extract helps against peptic ulcer by providing 
coating of mucilaginous matter. 
 
● FOR COLIC 
● CARMINATIVE 
Fenugreek stimulates digestive process. 





Fenugreek tea has soothing effect on inflamed stomach and intestine, further it is 
believed by the herbalists that it cleans the stomach, bowls and kidney 
(phytotherapies.org) (indianetzone.com) 
 ANTIPYRETIC EFFECT 




 EMOLIENT  
Fenugreek reduces skin irritation and inflammation on topical application 
(phytotherapies.org). 
 RESPIRATORY DISEASES 
Trigonella foenum-graecum tea has been traditionally used in the early stages of 
any of the respiratory infections such as bronchitis, influenza, sinusitis and catarrh, 
and pneumonia. 
 
 GALACTAGOGUE EFFECT (phytotherapies.org) 
The seeds of fenugreek have been used to make tea which is known to increase 
milk production in nursing women.  
Dosage: - Up to four cups of tea could be taken daily. 
Fenugreek seeds made in gruel and given to nursing women increases the flow of 
milk.  
It has also been given, along with sweets, to ladies in post natal period. 
 
Preparation of fenugreek tea 
Soak 0.5 gram (about 1/8 teaspoonful) of crushed seed in 1 cup of cold water for 3 
hours. Strain before drinking. Tea could be sweetened by honey. To improve 
flavor few drops of lemon also could be added. 
 
 FOR MOUTH- ULCERS 
An infusion of Trigonella foenum-graecum is being traditionally used as gargle for 
recurrent mouth ulcers. 
 VULNERARY EFFECT 
Fenugreek promotes healing of wounds (phytotherapies.org). 
 ANTI-DANDRUFF EFFECTS 
Trigonella foenum-graecum seeds are also being used to remove dandruff. 
 Two table spoons soaked overnight in water, softened in the morning, crushed and 
ground to make a paste like formulation and applied on scalp/ dandruff and left for 




Trigonella foenum-graecum seeds extract has been used traditionally to improve 
sexual desire and potency by the herbalist healers. 
 
 VETERINARY USES 
Trigonella foenum-graecum seeds fine ground and mixed with cottonseed fed to 
cows is a traditional remedy being used to increase the flow of milk. 
 
OTHER USES 
 IN PHARMACEUTICAL INDUSTRY 
Fenugreek also contain a sapogenin ―Diosgenin‖, it has steroidal structure and has 
been used as a starting material to produce sex hormones in the pharmaceutical 
industry. 
 AGAINST CANCER 
Fenugreek has been used in combination with a few other ingredients to formulate 
a preparation against cancer as described by (Ma, Zhu et al. 2006).  
This combination helps to reduce side effects related to chemotherapy. 
 AGAINST PROSTATA 
(Guo 2006) has described that fenugreek can be used along with a no. of other 
ingredients to design a formulation which can inhibit -receptor and delay the 










The composition of an average seed is as follows, (Hemavathy and Prabhakar 1989), 
(indianetzone.com):- 
Name of substance Content in percent 
Moisture 6.3% 
Protein 9.5% 






Iron 0.011 % 
Sodium 0.09% 
Potassium 1.7% 
Vitamin B1 0.41 mg/ 100g 
Vitamin B2 0.36 mg/100g 
Niacin  6mg/ 100 g 
Vitamin C 12.0 mg/ 100g 
Vitamin A 1040 I.U. / 100 g 
Calorific value 370 calories / 100 g 
Gums 23.06 % 




LEAVES STEM AND PODS:- 
Leaves stem and pods are also rich in Calcium, iron, vitamin A and Vitamin C. Although 
fresh leaves contain only 3-5 % protein, on dry basis, they are comparable to pulses 
(indianetzone.com). 
 
Trigonella foenum-graecum seeds also contain both volatile oils and fixed oils. 
● VOLATILE OILS 
The volatile oil content of fenugreek is less than 0.02% it is not commercially very important 
(indianetzone.com). 
● FIXED OILS 
The fixed oil content of the seed is about 6% (Hardman and Jefferies 1971). The fatty acids 
content of the seed is largely of oleic acid, linoletic and linoleic acids. It has marked drying 
properties, the dried oil being golden yellow in color, and insoluble in ether. The oil has 
disagreeable odor and bitter taste (indianetzone.com). 
 
CHEMICAL COMPOUNDS OF Trigonella foenum-graecum   ISOLATED BY 
EXTRACTIONS AND CHROMATOGRAPHY 
1. 4- Hydroxyisoleucine (Shah, Bodhankar et al. 2006). 
2. Trigonellin an alkaloid (Shah, Bodhankar et al. 2006). 
3. Flavonoids (Shang, Cai et al. 1998). 
5 different flavonoids have been isolated from fenugreek extract as Vitexin, Tricin, 
naringenin, quercetin, and tricin-7-O- -D-glucopyranoside. 
4. Glycosides  
 Galactomannan(Sun and Zhang 2008). 
 Furostanol (Hardman, Kosugi et al. 1980). 
5. Diosgenin (Jing and Zhao 2005) (Fazli and Hardman 1968). 
6. Protodioscin (Hibasami, Moteki et al. 2003). 
7. Trigoneocide VIII (Shang, Cai et al. 2001). 
8. Yamogenin(sapogenin) phytotherapies.org (Hardman and Jefferies 1971). 
9. Defensins(Tfgd2); 2 types of antifungal Defensins in fenugreek were detected by 
cloning and PCR (polymerase chain reaction) (Olli, Guruprasad et al. 2007) . 




1. HYPOGLYCEMIC EFFECT 
 (Shah, Bodhankar et al. 2006) studied the combination therapy with 
 4-Hydroxyisoleucine from fenugreek extract and a synthetic drug pioglitazone, on 
Alloxan-induced diabetic mice, and found that combined effect of both substances 
is stronger than each of them individually; also combination therapy with 4-
hydroxyisoleucine and pioglitazone is more beneficial than combination therapy 
with 4- hydroxyisoleucine and glyburide (Benzamide). 
These findings support and provides scientific basis of traditional usage of fenugreek in 
Pakistan and India as hypoglycemic herb. Also combination with fenugreek and the 
synthetic drugs lowers the effective dose of the synthetic drugs thus reducing the potential 
side effects related to therapy with the synthetic substances alone. 
These findings provide starting point for further research to minimize the potential side 
effects related to chemotherapy with synthetic substances. It could also be further 
researched to invent a co-formulation with  4-hydroxyisoleucine isolated from Fenugreek 
extract and synthetic drugs like pioglitazone, which may become a safer alternative as 
compared to synthetic drugs alone. Fenugreek can also be used as health food supplement. 
 
 (Shah, Bodhankar et al. 2006) studied the pharmacological effects of 
trigonelline extracted from fenugreek on the Alloxan induced diabetic mice and 
found that trigonelline  significantly reduced the blood glucose in treated groups as 
compared to control diabetic animals.  Trigonelline treated group showed islet 
cells in the vicinity of the pancreatic duct which indicates its beneficial effects on 
beta cells.  Glyburide (Benzamide) was used as a standard anti-diabetic drug and 
its effect on pancreatic cell was also studied.  The pancreatic beta cells of 
glyburide (Benzamide) treated mice did not show any islets in the vicinity of 
pancreatic duct.  Both trigonelline and glyburide arrested the decrease in body 
weight and mortality of diabetic mice.  LD50 of trigonelline was found to be more 
than 5000 mg/kg.    
 
Hypoglycemic effects of combination of two compounds isolated from Trigonella 
foenum-graecum, “4 hydroxyisoleucine‖ and ―trigonelline‖ (4HIT) by (Shah, 
Bodhankar et al. 2006) in alloxan induced diabetic mice.   
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These compounds were isolated by column chromatography from fenugreek seeds.  
The combination of 4 hydroxyisoleucine and trigonelline [4HIT, 40:30, and 120 
mg/kg] was administered orally in alloxan induced diabetic mice.  The parameters 
studied were blood glucose, histology of pancreas, body weight, mortality and 
acute oral toxicity.  4HIT (120 mg/kg) showed reduction in blood glucose level 
within 2 hours and reduced the peak blood glucose level at 6 hours during acute 
study. 
 After 28 days treatment with 4HIT, there was significant decrease in blood 
glucose level.  4HIT increased the glucose threshold as compared to only alloxan 
treated group.  
 Histology of pancreas showed formation of new islets near the vicinity of the 
pancreatic duct.  Decreased glycosylated Hb (hemoglobin) adds to the effect of 
4HIT.  Glyburide was used as a standard anti-diabetic drug and its effect on 
pancreatic cell was also studied.  The pancreatic beta cells of glyburide treated 
mice did not show any islets in the vicinity of pancreatic duct.  Both 4HIT and 
glyburide arrested the decrease in body weight and mortality of diabetic mice.  
LD50 was found to be more than 5000 mg/kg.   
Result 
These findings suggest that 4HIT showed hypoglycemic effect in alloxan induced 
diabetic mice.  The presence of the pancreatic islets in the vicinity of duct 





2. INDUCTION OF KEY LIVER ENZYMES INVOLVED IN CARBOHYDRATES 
AND LIPIDS METABOLISM 
Fenugreek extract induces liver enzymes involved in glucose and lipid metabolism 
(Rashad and Moharib 2008). 
 
The male white rats were fed with diets containing different Egyptian plant leaf fibers  
and the activities of some key liver enzymes of carbohydrate and lipid metabolism, as well as 
liver function test, were studied.   
The rats were fed for 8 weeks on 5 diets: high carbohydrate basal diet 1 (fiber-free) and 4 
experimental diets consisting of the first one substituted with 10% of each fiber (turnip, sugar 
beet, cabbage and fenugreek green).   
The activities of glucose 6-phosphate dehydrogenase , 6-phosphogluconate dehydrogenase , 
6-phosphofructokinase, fructose-1,6-bisphosphatase, ATP-citrate lyase, and malate 
dehydrogenase were significantly increased in rats fed with diets substituted with 10% of a 
cabbage and fenugreek green fibers (diets 4 and 5) for 8 weeks.  While a significant decrease 
in the activities of these enzymes was observed in the liver of rats receiving turnip and sugar 
beet fiber-containing diets (diets 2 and 3).   
The hepatic pyruvate kinase activity was significantly lower in rats fed on diet 5 throughout 
the feeding period (8 weeks).   
The activities of the enzymes of liver function were lower in serum of rats fed with 4 
experimental diets than the control group.   
Higher reduction in serum glucose concentration was observed in rats fed on diets 3-5, 
compared with the control.  A lower hepatic glycogen content was observed in the rats fed on 






 It can be concluded that rats fed on cabbage and fenugreek green fibers (diets 4 and5) 
Showed higher effects on:- 
1. Increasing the activities of some key liver enzymes which are involved 
in the metabolism of carbohydrates 6-phosphate dehydrogenase, 6-phosphogluconate 
dehydrogenase, 6-phosphofructokinase, fructose-1, 6-bisphosphatase, ATP-citrate 
lyase, and malate dehydrogenase. 
2. Reducing the transaminase enzymes. 
3. Lowering serum glucose levels. 
4. Lowering liver glycogen content  
than that of turnip and sugar beet fibers (diets 2 and 3) over the 8-wk feeding period.  
3. CHOLESTEROL LOWERING EFFECT 
 
(Joshi and Rajni 2007) studied the effect of fenugreek in lowering cholesterol. The 
following study demonstrated that fenugreek significantly lowers the total blood 
cholesterol. 
 
Raw, roasted and sprouted fenugreek (methi) (Trigonella foenum-graecum) seeds 
were fed to rats for 40 days at 2.5 and 5% levels to find the effect on the 
concentration of blood glucose, total cholesterol (TC), low density lipoprotein 
cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and 
triglyceride (TG).  
 A significant (p ≤ 0.05) decrease was observed in blood glucose, TC, LDL-C and 
TG levels, whereas a significant (p ≤ 0.05) increase was seen in HDL-C level as 
compared to control groups.  Maximum rise in the HDL-C level was observed in 





4. ANTIOXIDANT EFFECT 
(Annida and Stanely Mainzen Prince 2005) demonstrated antioxidant effect of 
fenugreek extract in streoptozotocin-induced diabetic rat model. The antioxidant 
effect was evaluated by estimating thiobarbituric acid-reactive substances and 
reduced glutathione and measuring the activities of catalase and superoxide 
dismutase in liver, heart, and kidney in diabetic rats.  Fenugreek leaf powder 
supplementation significantly lowered lipid peroxidation and significantly 
increased the antioxidant system in diabetic rats. Thus, fenugreek leaf powder 
reduces oxidative stress in experimental diabetes in rats.    
5. ANTI-LEUKEMIC EFFECTS 
Protodioscin (PD) induces apoptosis and inhibits growth of human leukemic cells 
(Hibasami, Moteki et al. 2003). 
(Hibasami, Moteki et al. 2003) done a clinical trial on human beings (HL-60 cells) 
to study effects of Protodioscin on viability of human leukemic cells and stomach 
cancer cells KATO III cells (cells in the gastric lining).Protodioscin isolated from 
fenugreek extract induces apoptosis and displayed strong growth inhibitory effect 
against HL-60 cells, but weak growth inhibitory effect on KATO III cells.  
Morphological change showing apoptotic bodies was observed in the HL-60 cells 
treated with PD, but not in KATO III cells treated with PD.  
 Flow cytometric analysis showed that the hypodiploid nuclei of HL-60 cells were 
increased to 75.2, 96.3, and 100% after a 3-day treatment with 2.5, 5, and 10 µM 
PD, respectively.  The fragmentation by PD of DNA to oligonucleosomal-sized 
fragments, that is a characteristic of apoptosis, was observed to be both 
concentration and time-dependent in the HL-60 cells.  These findings suggest that 
growth inhibition by PD of HL-60 cells results from the induction of apoptosis by 
this compound in HL-60 cells.    
 
PD= Protodioscin,          KATO III cells = Gastric cancer cell lining 




6. GALACTAGOGUE EFFECT 
(El Ridi and Shahat 1944)has discovered a lactation promoting factor, from oil 
extracted from fenugreek seeds after dietary experiments on rats.  
 The factor was concentrated by chromatographic adsorption of the nonsaponifiable 
matter. Twelve different fractions were separated; one of them was active in doses of 1 
mg/ kg body weight or in the proportion of 1:75,000 of the diet consumed. 
Spectrographic examination of the oil, its nonsaponifiable matter and the active 
concentrate revealed an inflection in the region near 300 milli micro; but none in the 
tocopherol region (290 milli micro). The position of the band did not change after 
oxidation.  
The nonsaponifiable matter contained 2.7 mg. % carotene, 25 mg. % sterols (of which 
1.5% was ergosterol), and 3 mg. % of phospholipids.  
 
7. COUNTERACTION OF HYPERGLYCEMIC SIDE EFFECTS ASSOSIATED 
WITH CORTISON TREATMENT 
When an alkaloid ―Trigonelline‖, isolated from fenugreek, given to rabbits   
Pre- injected with 0.5 mg/ kg, it countered the hyperglycemic effect 











 HYPOGLYCEMIC EFFECTS 
 (Rashad and Moharib 2008) experimentally demonstrated the induction of liver enzymes 
involved in carbohydrate and lipid metabolism by fenugreek in rats. 
Fenugreek extract showed the following effects:- 
●Increasing the activities of some liver key enzymes involved in carbohydrate and lipid 
metabolism. 
●Reducing the transaminase enzymes 
●Lowering serum glucose levels 
●Lowering liver glycogen content  
 The above effects give scientific basis for traditional usage of fenugreek against 
hyperglycemia in Pakistan and India. 
Hypoglycemic effect of Trigonella foenum-graecum on rats has been described by   (Shah, 
Bodhankar et al. 2006) in total 3 studies done on Alloxan induced diabetic mice with 2 active 
ingredients 4-hydroxyisoleucine and Trigonelline, both of these substances has shown 
hypoglycemic effects.  
When a combination of 4 hydroxyisoleucine and trigonelline was administered                        
(4HIT, 40:30, and 120 mg/kg) this combination acts by regeneration of islets of langerhan 
near pancreatic duct leading to production of more insulin and reducing blood sugar level to a 
remarkable level. 
 
Another study done by (Annida and Stanely Mainzen Prince 2005) demonstrated that 1g/ Kg 
body weight of fenugreek has same effect like synthetic drug Glibenclamide. 
These studies done on rats could be either extrapolated to human beings or used to design 
clinical trials in human beings to check relevant effects. Because fenugreek has been proved 
safe and useful hypoglycemic agent traditionally that is why these findings may supports and 
provide scientific basis for traditional usage of fenugreek against Diabetes mellitus in Pakistan 
and India. Also combination with fenugreek and the synthetic drugs lowers the effective dose 
of the synthetic drugs thus reducing the potential side effects related to therapy with the 
synthetic substances alone. 
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These findings provide starting point for further research to minimize the potential side 
effects related to chemotherapy with synthetic substances. It could also be further 
researched to invent a co-formulation with 4-hydroxyisoleucine and the synthetic drugs 
like pioglitazone, which may become a safer alternative as compared to synthetic drugs 
alone. 
 COUNTERACTION OF HYPERGLYCEMIA INDUCED BY CORTISON  
 As described by the studies done by (Menczel and Korine 1964) on rabbits that trigonelline 
alkaloid isolated from fenugreek counters hyperglycemia induced by pre treatment with 
cortisone treatment. These findings could be used to design a clinical trial to check its 
efficacy in the patient groups (like cancer patients receiving cortisone treatment on long term 
basis to counteract side effects of chemotherapy/ radiation therapy like vomiting). And it may 
prove helpful to counteract hyperglycemia in those persons. 
 CHOLESTEROL LOWERING EFFECT 
(Joshi and Rajni 2007) demonstrated cholesterol lowering effect of fenugreek seeds on 
rats and this study could either be extrapolated to human beings or used to design 
clinical trials. Further this study gives a scientific basis for traditional usage of 
fenugreek in lowering cholesterol in Pakistan and India. 
 
The principles derived from fenugreek may become a future combined treatment 
regime with synthetic cholesterol lowering drugs for cholesterol lowering, either 
being used in co-formulations or as a health food supplement (It has already being 
marketed as a health food supplement in the market of traditional herbal remedies 
in the countries like Pakistan, India and china etc).  
 ANTI-LEUKEMIC EFFECTS 
(Hibasami, Moteki et al. 2003) demonstrated in a human clinical trial induction of 
apoptosis in the Human leukemic cells by a Protodioscin isolated from fenugreek. This 
fact indicates the possibility of adjuvant treatment with the modern synthetic drugs 
and fenugreek which could further lowers side effects related to synthetic 
chemotherapy and it opens chances of further research. 
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 GALACTAGOGUE EFFECT 
(El Ridi and Shahat 1944) described galactagogue principles in the fenugreek extract 
by testing in dietary experiments on rats; also fenugreek has been used both by nursing 
mothers and in veterinary practices to promoter secretion and flow of milk, in buffalo 
and cows, without any side effects. It gives the scientific basis for traditional usage of 
fenugreek as galactagogue. It could be further tested by designing clinical trials in 
nursing human mothers and its efficacy could be compared to oxytocin. 
 DIOSGENIN PRODUCTION FROM FENGREEK 
(Fazli and Hardman 1968) isolated diosgenin from fenugreek extract by a series of 
hydrolysis and extractions. Presence of a number of other associated steroids like 
Gitogenin, tigogenin, and 25 alpha-spirostane have been detected by thin layer 
chromatography. Yamogenin is not separated from diosgenin.  
This study shows presence of diosgenin, a sapogenin containing steroid structure 
which has been used as a starting material for the synthesis of sex hormones. 
1. No clinical/ animal studies are not yet available for the aphrodisiac effects, effect 
against gastritis, effect against gastric ulcers, mouth ulcers and effect against 
respiratory tract diseases of Trigonella foenum-graecum despite of the matter of fact 
that fenugreek has proved useful for these effects traditionally in Pakistan and India 
after years after years usage. 
2. Toxicological studies has not yet been reported and this is a need of the hour to design 
toxicological studies along with clinical trials, also the studies should be extended to 
check effects and dose adjustments in liver and renal compromised individuals so that 
fenugreek could be added as adjuvant to the modern treatment to overcome the side 
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 BOTANICAL NAME: - Carica papaya (Linn)  
 ENGLISH NAME: - Papaya 
URDU/ LOCAL NAME: - Papeeta  
FAMILY: - Caricaceae 
 
 
PARTS OF PLANT USED:- 
Fruit pulp, seeds, roots, leaves. 
ETHNOPHARMACOLOGY 
USES IN PAKISTAN 
1. Contraception ( Unripe fruit ) 
2. Anthelmentic  




 Ring worm, the mature ripe fruit is used. 



















1. FRUIT (Pendzhiev 2002):- 
The milky juice (latex) of papaya fruits is a source of proteolytic enzymes  
(Papain, chymopapain, peptidases A and B, and lysozyme), these enzymes possess 
Anti-inflammatory, anticoagulant, analgesic, bactericidal, anthelmentic and hemolytic 
properties. Capable of decomposing the proteins to polypeptides and amino acids and 
dissolving necrotized cells (while not affecting intact ones); these enzymes are widely 
used in medicine. 
 
 Papain, a cystein protease enzyme which is used for digestive problems as tablets. 
 
(Azadbakht, et al. 2006) described a method for isolation and study papain 
enzymes from Carica papaya as follows:- 
MATERIALS AND METHOD 
The full-grown but unripe fruit was subjected to shallow incisions on several sides 
(depth of incision was important).  After collection of 100 gram latex, the 
coagulated lumps were shredded and dried by the use of heat (30ºC).   
Extraction and sedimentation procedures were used for extraction of papain.  In 
this method, cysteine hydrochloride at adjusted pH was used for extraction and 
sodium chloride for sedimentation. 1.2 gram of Papain was isolated from 100 gram 
latex after extraction and sedimentation.   
 71 
 
The extracted papain was identified by the use of an electrophoresis method and 
also by comparing its IR (infrared spectrum) with the standard papain.  The 
activity of extracted papain was detected by USP (United States Pharmacopoeia) 
procedure.  Electrophoresis pattern and IR spectrum of extracted papain were 
identical with the standard papain. 
 (Chen, Hsu et al. 2007) described the presence of chitinase a glycosyl 
hydrolase. 
2. SEEDS 
Following fatty acids have been found in seeds (Pendzhiev 2002):- 
(i) Oleic acid (75.5%) 
(ii) Palmitic acid (11.38%) 
(iii) Stearic acid (5.25%) 
(iv) Linolic acid (2.13%), and 
(v) Arachidonic (0.31%) acids 
3. LEAVES (Pendzhiev 2002):- 
The leaves of papaya contain free and bound phenolic compounds, tannins, organic 
acids, steroidal and triterpene saponins, flavonoids, lipids, coumarins, glycosides, and 
alkaloids.  
 
The crust of the tree contains a substance effectively suppressing the growth of some 







1. CONTRACEPTIVE AND ABORTIFACIENT PROPERTIES 
 
 ABORTIFACIENT AND CONTRACEPTIVE EFFECTS IN WOMEN 
The scientific research work has been done by the Britain‘s university of Sussex, 
which proves the contraceptive qualities of Carica papaya fruit (Asia week, 1994). 
Mechanism of Action 
 
The Carica papaya contain en enzyme called Papain which suppresses 
Progesterone, a hormone which is needed to maintain conception and maintain 
pregnancy.  
Another possibility may be papain which can be used to tenderize meat may break 
down a membrane vital to the development of the fetus. 
Recommended dose 
 
● CONTRACEPTIVE EFFECTS 
In Siri-lanka, India and Pakistan, the traditional healers recommend eating unripe 
papaya fruit daily to avoid pregnancy in young women. 
When pregnancy is required it could be attained by just stopping usage of papaya. 
 
● ABORTIVE EFFECTS 
                    (Tharmalingam Senthilomohan, rep. by Asia week 1994) recommends that 
abortion could be induced by consumption of unripe fruit of Carica papaya for 3 consecutive 
days. 
 
 (Oderinde, Noronha et al. 2002)studied the abortifacient potential of aqueous 





AIM OF THE STUDY 
 
Experiments were conducted to investigate the abortifacient potential of aqueous extract of 
Carica papaya (Linn) seeds in female Sprague-Dawley rats.  Oral doses of 100 and 800 
mg/kg body weight were administered once a day from days 1 to 10 post-coitum.  No 
significant differences in total body weight were found in fetuses exposed to these regimes.  
However, in the group treated with 100 mg/kg body weight, there was a significant increase 
(p < 0.05) in the implantation sites and fetal weight was significantly decreased (p < 0.05) 
compared to the controls.  No dead or malformed fetuses were found.  However, in the group 
treated with 800 mg/kg body weight, there was obvious vaginal bleeding but no treatment 
related increase in implantation sites compared with control.  There was however, complete 
resorption of about 30% of the fetuses.  The surviving fetuses were stunted when compared 
with the control but were without any external malformations.  The results of the present 
investigations lead to the clear conclusion that low dose aqueous crude extract of 
 Carica papaya (Linn) seeds do not adversely affect prenatal development.  The altered 
toxicological profile indicates that the abortifacient property is a high dose side effect.  The 
results indicate that Carica papaya toxicity can adversely affect the fetus. 
 CONTRACEPTIVE EFFECTS IN MALE 
(Lohiya Nirmal, Manivannan et al. 2006) demonstrated a significant male anti-
fertility effects of Carica papaya seeds extract in the following pharmacological 
study on albino rats:- 
 
In this study there were studied semen profile, fertility, body and organ weight 
response, and toxicology in male albino rats.  The Carica papaya seed extract was 
administered at the dose regimens of 10 and 50 mg/animal/day orally for 30, 60, 
and 90 days and 0.1 and 1.0 mg/animal/day intramuscularly for 15 and 30 days.   
Caudal epididymal sperm motility and count was reduced significantly at low and 
high dose regimens both in the oral as well as the intramuscular groups.  The 
reduced sperm motility was associated with morphological defects.  Testicular 
sperm counts were also reduced in all the treatment groups except the low dose 
intramuscular group.  Fertility tests showed dose- and duration-dependent 
reduction and zero fertility was observed at high dose regimens of the oral and 
intramuscular groups following 60 and 30 days of treatment, respectively.  
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Testicular weight was reduced in all the treatment groups, whereas accessory sex 
organs showed a variable response.  Body weight and toxicological observations 
did not show any untoward response.  Fertility and all other associated changes 
returned to normal within 45 and 30 days of treatment cessation in the oral and 
intramuscular groups, respectively. 
 
RESULT 
 The data revealed that reversible sterility could be induced in male rats by papaya 
seeds aqueous extract treatment without adverse effects on libido and toxicological 
profile. 
2. ANTI-PARASITAL EFFECTS 
●ANTHLMENTIC ACTIVITY 
(Stepek, Lowe et al. 2007)examined the mechanism of action and compared the anthelmentic 
efficacy of cystein proteinases from papaya, pineapple, fig, kiwi fruit and Egyptian milkweed 
in vitro using the rodent gastrointestinal nematode Heligmosomoides polygyrus. Within a 2 
hour incubation period, all the cystein proteinases, with the exception of the kiwi fruit extract, 
caused marked damage to the cuticle of H. polygyrus adult male and female worms, reflected 
in the loss of surface cuticular layers. Efficacy was comparable for both sexes of worms, was 
dependent on the presence of cystein and was completely inhibited by the cystein proteinase 
inhibitor, E-64. LD50 values indicated that the purified proteinases were more efficacious 
than the proteinases in the crude latex, with purified ficin, papain, chymopapain, Egyptian 
milkweed latex extract and pineapple fruit extract, containing fruit bromelain, having the most 
potent effect.  
 
RESULT 
Carica papaya along with the other plants under study (except kiwi) exhibited a potent 
anthelmentic effect. 
The mechanism of action of these plant enzymes (i.e. an attack on the protective cuticle of the 
worm) suggests that resistance would be slow to develop in the field.  
●ANTI-Trichomonas vaginalis EFFECT 
(Calzada, Yepez-Mulia et al. 2007) performed the invitro susceptibility assay on crude 
methanolic extracts from 22 Mexican medicinal plants. All these plants under study were 
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screened for anti-trichomonal activity against Trichomonas vaginalis, which is the etiological 
agent of trichomoniasis. Among the plants tested Carica papaya and Cocos nucifera showed 
the best anti-trichomonal activity with IC50 values of 5.6 and 5.8µg/ml, respectively.  
The extracts of Bocconia frutescens, Geranium mexicanum, and Lygodium venustum showed 
moderate activity with IC50 values ranging from 30.9 to 60.9 µg/ml. All the other plant 
extracts were inactive (IC50 > 100µg/ml). All extracts tested were less active than 
metronidazol (IC50 0.037µg/ml); an antiprotozoal drug used as positive control.  
 
RESULT 
Carica papaya (and Bocconia frutescens) has shown best anti-trichomonal activity. 
 
 
IC 50= Inhibitory concentration required to kill 50 % of the organisms under test. 
 
●ANTI-FUNGAL PROPERTIES 
(Chen, Hsu et al. 2007) described the presence of Chitinase enzyme in Carica papaya fruit in 
the following study:- 
              Chitinase cDNA clone (CpCHI, 1002 bp) was isolated from papaya fruit, which 
encoded a 275 amino acid protein containing a 28 amino acid signal peptide in the N-
terminal end. 
               The predicted molecular mass of the mature protein was 26.2 kDa (Kilo Dalton), and 
its pI value was 6.32. On the basis of its amino acid sequence homology with other 
plant chitinases, it was classified as a class IV chitinase. An active recombinant 
CpCHI enzyme was over expressed in Escherichia coli. The purified recombinant 
papaya chitinase showed an optimal reaction temperature at 30ºC and a broad optimal 
pH ranging from 5.0 to 9.0. The recombinant enzyme was quite stable, retaining >64% 
activity for 3 weeks at 30 ºC. The spore germination of Alternaria brassicicola could 
be completely inhibited by a 76 nM level of recombinant CpCHI.  
            Recombinant CpCHI also showed antibacterial activity in which 50% of  
            E. coli was inhibited by a 2.5 micro Molar concentration of the enzyme.  
_______________________________________________________________ 
cDNA= complimentary DNA produced by reverse transcriptase 
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N- terminal= Refers to the end of protein or polypeptide terminated by an amino acid 
with a free amino group. When protein is translated from mRNA, it is created from 
N-triminal to C-terminal. 
PI value= means percent inhibition value 
nM= nanomolar concentration 
 
 
TREATMENT OF DIGESTIVE INSUFFICIENCY 
(Bykov, Demina et al. 2000) described the usage of papain enzyme, isolated from 
Carica papaya extract, in the co-formulations along with other enzymes needed to 
cure digestive insufficiency. 
 




3. ANTI-OXIDANT PROPERTIES 
(Mehdipour, Yasa et al. 2006)studied the anti-oxidant properties of Carica papaya juice both 
in laboratory and pharmacological studies in rats and found the anti-oxidant properties are 
comparable to α-tocopherol. The study done by (Mehdipour, Yasa et al. 2006) is as follows:- 
  
AIM OF THE STUDY 
 The present study was designed to explore the toxicological and antioxidant potential of dried 
Carica papaya juice in vitro and in vivo.  
 
The oral LD50 of the juice of Carica papaya was determined, and the antioxidant potentials 
determined by DPPH and FRAP tests. 
  
In vivo examination was performed after oral administration of dried papaya juice to rats for 2 
weeks at doses of 100, 200 and 400 mg/kg. Blood TBARS and FRAP assays were used to 
determine the potential of the juice to act against oxidative stress. The acute toxicity test 
(LD50) demonstrated that papaya juice is not lethal up to a dose of 1500 mg/kg after oral 
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administration and thus is considered nontoxic. In treated groups, no sign of toxicity was 
observed. 
 
 In vitro evaluation of the antioxidant effects of papaya showed that the highest antioxidant 
activity (80%) was observed with a concentration of 17.6 mg/ml. Blood lipid peroxidation 
levels decreased significantly after administration of all doses of papaya juice (100, 200, 400 
mg/kg/day) to 35.5%, 39.5% and 40.86% of the control, respectively, compared with a value 
of 28.8% for vitamin E. The blood total antioxidant power was increased significantly by all 
doses of papaya juice (100, 200, 400 mg/kg/day) to 11.11%, 23.58% and 23.14% of the 
control, respectively. The value for vitamin E was 18.44%. This preliminary study indicates 
the safety and antioxidative stress potential of the juice of C. papaya, which was found to be 
comparable to the standard antioxidant compound α-tocopherol.  
 
 
DPPH= Diphenyl picryl hydrazyl 
FRAP= Ferric reducing ability of plasma 
TBARS= Thio barbituric acid 
LD 50= Lethal dose required to kill 50 % of the organisms under study 
 
4. MEDICINAL USES OF PAPYA ENZYMES 
(Pendzhiev 2002) isolated different enzymes present in Carica papaya extract 
including proteolytic enzymes (papain, chymopapain, peptidases A and B, and 
lysozyme) having anti-inflammatory, anticoagulant, analgesic, bactericidal, 
Anthelmentic and hemolytic properties. These enzymes are capable of decomposing 
the proteins of polypeptides and amino acids and dissolving necrotized cells (while not 
affecting intact ones); these enzymes are widely used in medicine. 
USE OF ENZYMES IN SURGERY 
● The proteolytic and anti-inflammatory properties of papain allow this enzyme to 
be applied in surgery for the treatment of various fistulas, cleaning wounds from 
necrotized tissues, and preparing trophic ulcers for skin grafting epidermatoplasty). 
Good cleaning of wounds and the improved condition of soft tissues allowed the 
duration of using metal structures to be prolonged, thus increasing the 
consolidation of broken bones.  
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● The ability of papain to soften and partly dissipate newly formed pathological 
connecting tissues and hematomas is employed in ophthalmology. The proteolytic 
enzyme preparations are introduced by the Burgignon technique with the aid of an 
eye-bath, by endonasal electrophoresis, or by phonophoresis. 
 
●Papain is also used in neurosurgery for facilitating cicatrical adhesions in the 
shells of brain and spinal cord, peripheral nerves, and spinal roots, which are 
typical complications of many neurosurgical disorders. The enzyme preparations 
are also used for the treatment of open and closed craniocerebral injuries and 
spinal-cord traumas, inflammatory and degenerative processes in the spinal 
column and ligamentous apparatus, and various formations in the peripheral 
nervous system. The use of proteolytic enzymes significantly improves the total 
effect of the active surgical invasion.  
  
●In orthopedics, papain is used in vertebral surgery for the treatment of lumbar 
osteochondrosis (intravertebral introduction).  
 
●Papain can be also employed for the treatment of intravertebral disk herniation 
and connective tissue disorders, such as the initial stage of Dupuytren‘s 
contracture. In the stage of pronounced digital contracture, papain can be used for 
partly decreasing the degree of contracture, preparing soft tissues for operation, 
and eliminating post-operation recidivations. 
  
●In urology, papain can be used for the treatment of prostatitis by electrophoretic 
methods.  
 
Due to presence of phenolic compounds, tannins, organic acids, glucose, 
flavonoids, lipids, coumarins, steroidal and triterpene saponins, and alkaloids,  
the leaves of papaya possess biligenic(bile like) properties. Papain was used in phlebology for 
the treatment of chronic venous insufficiency of lower extremities, which is typically caused 
by the primary varix dilatation or deep venous thrombosis. In surgical cosmetology, papain is 
used for accelerating post-operation scar tissue resorption and debriding small residual traces 
(hypertrophic and keloid scars) after plastic operations. 
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In gastroenterology, papain preparations are used for the treatment of gastritis, gastric ulcers, 
and constriction of Schatzki‘s ring (esophageal ring), [(Abdullaev, et al. 1998), (Pendzhiev, et 








 (Wilson, Kwan et al. 2002) performed the following pharmacological study on 
animals (dog carotid artery) to study the effects of Carica papaya extract on 
mammalian vascular smooth muscles. 
AIM OF THE STUDY 
 To investigate their potentially toxic effects on mammalian vascular smooth muscle. 
MATERIALS AND METHODS 
Pentane extracts of papaya seeds and the chief active ingredient in the extracts, benzyl 
isothiocyanate (BITC), were tested for their effects on the contraction of strips of dog carotid 
artery. BITC and the papaya seed extract caused relaxation when added to tissue strips that 
had been pre-contracted with phenylephrine (PE). Incubation of the tissue with papaya seed 
extract or BITC caused inhibition of contraction when the strips were subsequently contracted 
with KCl (Potassium chloride) or PE. 
This relaxation and inhibition of contraction did not appear to be endothelium-dependent, as 
endothelium-denuded rings showed the same degree of relaxation or inhibition of contraction 
in response to the preparations/drugs as those with the endothelium intact. Inhibition of 
relaxatory effects of carbachol (CCh) further supports this relaxatory effect independent of 
endothelial derived relaxatory factors. 
The effects of both BITC and the extract were irreversible, i.e., the tissue did not recover to 
normal contractile ability after extensive washing. Exposure of the tissue to the papaya seed 
extract caused slower relaxation of the tissue, compared to controls, both after contraction 
with PE and subsequent addition of carbachol (CCh), and after contraction with KCl and then 
washing. Calcium imaging studies using cultured endothelial cells showed strong influxes of 
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Ca2+ into the cells, in a tissue specific manner, in response to addition of the papaya seed 
extract. 
RESULT 
It was concluded that these extracts induced vasorelaxatory effects on vascular smooth 
muscles in a dose dependent manner; when present in high concentration, are cytotoxic by 
increasing the membrane permeability to Ca2+ it would interfere with the ability of vascular 
smooth muscle to maintain vascular tone, and lead to toxic effects in the animal causing 
paralysis of cells as is evident by the morphological changes in cells. The vascular effects of 




Carica papaya extracts contains a bio-active ingredient benzyl isothiocyanate (BITC) which 
is responsible for the relaxatory/ vasodilatory effect of its extract. But increased influx of Ca 
2+ causes cytotoxicity. 
 
  (Mehdipour et al, 2006) determined in studies in rats that up to 1500mg/ Kg body 
weight is not toxic. 
 Carica papaya unripe fruit has also been traditionally used as Abortifacient that is 








 CONTRACEPTIVE AND ABORTIFICIENT EFFECTS 
The studies done by Britain‘s University of Sussex (Asia week, 1994) have proven the 
abortifacient and contraceptive effects of Carica papaya in women. The proteolytic 
enzyme Papain present in unripe fruit of papaya has been suggested to be the 
ingredient responsible for this effect. It suppresses the progesterone and can also break 
down a membrane vital for the development of fetus. 
 
(Oderinde 2002) demonstrated dose dependent abortifacient effects of unripe Carica 
papaya fruit extract in animal studies done in rats. Further it was observed that 
abortifacient potential is related to higher doses greater than 800mg/kg. 
 
These facts give scientific basis for abortifacient and contraceptive usage of unripe 
fruit of Carica papaya in Asia Minor. 
 TREATMENT OF DIGESTIVE INSUFFICIENCY 
(Bykov et al, 2000) The persons having abnormal enzyme production due to disease 
conditions like Chronic pancreatitis with extrasecretory insufficiency,  pancreatectomy 
and pancreatic cell carcinoma, liver and bile tract disorders upon stomach and/or small 
intestine resection , chronic enteritis, gastritis with secretory insufficiency etc, needs 
treatment with digestive enzymes like, pepsin, lipase and papain . The extract obtained 
from Carica papaya is rich in Papain proteolytic enzyme along with other enzymes, is 
a part of commercial preparations to cure digestive insufficiency. These facts support 






> ANTI-PARASITAL EFFECTS 
●ANTHELMENTIC EFFECTS 
The scientific work done by (Stepak et al, 2007) proves the traditional anthelmentic 
usage of Carica papaya in humans and livestock. 
In addition the mechanism of action of these plant enzymes (i.e. an attack on the protective 
cuticle of the worm) suggests that resistance would be slow to develop in the field.  
The efficacy and mode of action make plant cystein proteinases potential candidates for a 
novel class of anthelmentic urgently required for the treatment of humans and domestic 
livestock. However the toxicity and the potential side effects should be further researched to 
find the safe and effective dosages. 
●ANTI-TRICHOMONAL EFFECTS 
(Calzada 2007) concluded, in the in vitro scientific work done on the Trichomonas vaginalis; 
vaginitis causing parasite, that Carica papaya extract shows the best inhibitory concentration 
with IC 50 5.6 µg/ ml .The results of the antiprotozoal screening support the traditional usage 
of Carica papaya for urogenital disorders.  However, seeds of Carica papaya and aerial parts 
of Bocconia frutescens should be used in herbal medicine with care to avoid toxicity. 
There is also need for the clinical studies and the studies to find out the active ingredients 
responsible for this effect. 
 
●ANTI-FUNGAL ACTIVITY 
(Chen, Hsu et al. 2007) described the presence of Chitinase enzyme (glycosyl 
hydrolase) in the Carica papaya fruit; this enzyme contributes to plant defense due to 
their ability to degrade the cell wall and inhibit the growth of fungal pathogens. These 
facts support the traditional usage of Carica papaya as anti-fungal. Further 
pharmacological research could lead to a novel pharmaceutical topical anti-fungal 
ointments or cream, which could treat effectively the problem of various types of 
fungus infections in humans. 
It could also be employed as a natural defense against pathogens to economically 




 ANTI-OXIDANT EFFECTS 
(Mehdipour et al, 2006) demonstrated by both in vivo and in vitro studies that 
 the anti-oxidant potential of Carica papaya is comparable to the α-tocopherol 
supports the traditional usage of Carica papaya for various types of ailments.  
The anti-oxidant activity may be due to presence of flavonoids and vitamin C. 
 
The inhibition of lipid peroxidases in the studies done by (Mehdipour et al, 2006) may 
support the usage of Carica papaya as analgesic and anti-pyretic in the traditional 
health care settings in Pakistan and India. 
 VASODILATORY EFFECTS 
(Wilson, Kwan et al. 2002) studied the relaxatory effects caused by the Carica papaya 
extract on intact dog artery. The papaya extract contains benzyl isothiocyanate (BITC) 
which is responsible for vasodilatory effects, which is independent of endothelial 
derived relaxatory factors i.e. Nitric oxide (NO) etc. 
   
The increased influx of Ca2+ damages the cells as is observed by the morphological 
studies of dog carotid artery after exposure to Carica papaya extract (BITC) in a dose 
dependent manner. 
The calculated lethal dose for Caenorhabditis elegans [a free living nematode (round 
worm)] is 0.04-0.1 µL in a 0, 5 ml in vitro assay (1:1000). 
When Carica papaya containing BITC is taken orally it result in a final dilution of 1:40,000 
which is equivalent to a BITC dilution of about 1:4,000,000 or 0.19 µM, assuming that it is 
widely distributed in the body tissues( there is about 40 Liter water in the human body). After 
dilution BITC reaches up to a level which does not cause irreversible relaxation/ damage to 
tissues.  
 
These facts may support the traditional usage for high blood pressure. However further 
detailed clinical research is needed before Carica papaya extract could be recommended to 





 MEDICINAL USES OF PAPA ENZYMES 
(Pendzhiev 2002) described various applications in surgery, of enzymes isolated from 
milky juice obtained from Carica papaya fruit. This scientific work gives scientific 
basis for traditional usage of Carica papaya for various diseases. 
These facts indicate that the Carica papaya contains proteolytic enzymes which offer the 
same chondrolytic properties close to those of the analogous imported preparations. Using this 
domestic preparation, it is possible to ensure the effective therapy of patients with various 
disorders and restrict the use of deficient and expensive preparations. This could be a good 
alternative for a developing country like Pakistan etc. 
 
Chondrolysis= the degeneration of cartilage cells that occurs in the process of 
intracartilaginous ossification (formation of cartilages). 
 COSMETIC INDUSTRY 
Carica papaya enzymes has also been used by the cosmetic industry in the production 
of exfoliating creams, skin shining creams, anti-wrinkle and skin protecting 
formulations (Shetgiri, Shetgiri et al. 2008), (Cho, Kim et al. 1999; Ye 2004), (Ye 
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BOTANICAL NAME:-Dioscorea floribunda M.Martens& Galeotti 
URDU/ LOCAL NAME: - Ratalo  
FAMILY: - Dioscoreaceae 
PARTS OF PLANT USED:- 
Dried root tuber. 
DESCRIPTION 
Dioscorea floribunda is cultivated in tropical and subtropical regions of the world as a source 
of natural diosgenin. Various steroidal drugs like corticosteroids, sex hormones and anabolic 
steroids are derived from diosgenin by artificial synthesis.  
Dioscorea floribunda like other yams is a tropical plant and requires a long frost-free growing 
season. The palm like pyramidal tuber is divisible into three distinct parts -crown (stem end 
with preformed buds), median (middle) and tip (distal end). All the three parts are used for 
vegetative propagation (Bammi, RK et al. 1982). A monsoon climate followed by a dry 
season with shorter days is ideal for the cultivation of this crop (Martin, FR. 1972). Both day 
length and temperature influence the developmental cycle. In the spring, when the days 
lengthen and temperature increases, the plants develop vigorous vines, and with the change in 
season the rate of tuber development increases as the days become shorter. Finally, a time is 
reached, apparently controlled by day length but also influenced by the availability of water 
and by low temperature, when the vines die back and the tuber enters a period of dormancy. 
The tubers are able to withstand low temperature and sprout again in spring to follow a 
normal life cycle. It has been suggested that ABA (Abscisic acid) may be involved in the 
dormancy mechanisms of tubers of other vegetable species (Coleman, WK. et al. 1984) and 







USES IN PAKISTAN 
 ANTITUSSIVE 
USES IN ENGLAND 
 Rheumatoid arthritis to relive pain and inflammation 
(British herbal pharmacopoeia) 
CHEMISTRY 
 The principle ingredients present are saponin glycosides of which sapogenin (non 
glycoside portion ―aglycon‖) ―DIOSGENIN‖is therapeutically important. 
             (De and De 2005) 
 
Structure of Diosgenin as proposed by (Anthony, C. et al. 2002) 
 
 Genetic improvement(cloning)  gave increased Diosgenin production as studied by 
(Dixit, Banerji et al. 2000). 
 
 Abscisic acid and pthalic acid and Batatasin-1 are present. Concentrations of these 
growth inhibitors vary during dormancy and active growth periods as studied by 




 The root also contains phytosterols, alkaloids, tannin and a high level of starch. Other 
materials present include Aluminum, Ascorbic-acid, Ash, Beta-carotene, Calcium, 
Chromium, Cobalt, Iron, Magnesium, Manganese, Niacin, Phosphorus, Potassium, 





1. ANTIPHLOGISTIC EFFECTS 
Saponins and sapogenins were tested for anti-inflammatory effects in rats and mice at 
a rate of 10 mg/kg using exudative and proliferative models. The strongest 
antiphlogistic effect was seen amongst the furostanic group of saponins (which yield 
diosgenin) as studied by (Syroc et. al, 1992). 
 
 
2. OESTROGENIC EFFCTS 
Diosgenin was given to ovariectomised mice at 20 & 40 mg/kg daily for 15 days. The 
diosgenin stimulated the growth of mammary epithelium as shown by an increase in 
DNA content, number of ducts and the appearance of terminal end buds. Concomitant 
treatment with oestrogen and diosgenin showed augmentation of the oestrogenic effect 
of diosgenin especially at the higher dose. Diosgenin showed a lack of progesterogenic 
activity as shown by the absence of alveolar development even in the presence of 





3. TREATMENT OF BREAST CANCER 
The role of Diosgenin in the treatment of breast cancer was studied by  
(Chiang, Way et al. 2007)in the following study:- 
Fatty acid syntheses (FAS) expression is markedly elevated in HER2-overexpressing 
breast cancer cells. In this study, diosgenin, a plant-derived steroid, was found to be 
effective in suppressing FAS expression in HER2-overexpressing breast cancer cells. 
Diosgenin preferentially inhibited proliferation and induced apoptosis in HER2-
overexpressing cancer cells. Furthermore, diosgenin inhibited the phosphorylation of 
Akt and mTOR, and enhanced phosphorylation of JNK. The use of pharmacological 
inhibitors revealed that the modulation of Akt, mTOR and JNK phosphorylation was 
required for diosgenin-induced FAS suppression. Finally it was proved that diosgenin 
could enhance paclitaxel-induced cytotoxicity in HER2-overexpressing cancer cells. 
These results suggested that diosgenin has the potential to advance as chemo 
preventive or chemotherapeutic agent for cancers that over express HER2.  
 
4. ANTIAGING EFFECT 
Diosgenin has shown anti aging effect owing to stimulation of estrogenic receptors in 
the skin, anti wrinkles effect and anticollagenase activity as shown by the following 
studies:- 
 ANTI WRINKLES EFFECT 
Sapogenin (non glycoside portion of a saponin glycoside) is a part of external 
formulation to treat wrinkles (Besne 2003). 
 ANTICOLLAGENASE ACTIVITY  
Sapogenin portion of Dioscorea floribunda (Diosgenin) extract exhibits anticollagease 
activity thus contribute to keep firmness of skin and  
protect against/ slowdown aging as studied by  (Liviero and Allec 2002).  
 
 FACE LIFT THROUGH MUSCULO-APONEUROTIC SYSTEM 
Diosgenin by interacting with musculo-aponeurotic system or the receptors of 




5. VASODILATORY EFFECT  
Vasodilatory/ vasorelaxant effect of Dioscorea extract was studied by (Dias, Correia et 
al. 2007) in the following study:- 
MATERIALS AND METHODS 
The aim of this study was to investigate the vasorelaxant effect induced by diosgenin in 
superior mesenteric rings in rat superior mesenteric artery. In rings pre-contracted with 
phenylephrine (10μM), diosgenin caused concentration-dependent relaxations [EC50 = (3.3 ± 
1.2) × 10
− 4
M, Emax = 94.2 ± 2.6 %]. Vascular relaxation induced by diosgenin was 
significantly inhibited after removal of the endothelium (Emax = 46 ± 8.8%, p < 0.001) or after 
pre-treatment of the rings with N-nitro-l-arginine methyl esther (l-NAME) 100 or 300μM 
(Emax = 35.3 ± 4%; 28.1 ± 3.3%, respectively, p < 0.001), atropine 1μM (Emax = 24.6 ± 3.4%, 
p < 0.001), hydroxocobalamin 30μM (Emax = 54.0 ± 9.6%, p < 0.001), 1H-[1,2,4]oxadiazolo-
[4,3-a]quinoxalin-1-one (ODQ) 10μM (Emax = 46.0 ± 8.0%, p < 0.001) or indomethacin 1μM 
(Emax = 22.6 ± 11.8%, p < 0.001). Vasorelaxation evoked by diosgenin was significantly 





 (BKCa) channels, iberiotoxin 100nM or tetraethyl 
ammonium (TEA) 1mM, respectively (Emax = 62.5 ± 9.1%; 65.7 ± 1.1%, p < 0.001).  
Conversely, in endothelium-denuded vessels, none of BKCa channel blockers modified the 
relaxant effect induced by diosgenin. In mesenteric endothelial cells loaded with FURA-2 
diosgenin was able to increase intracellular calcium concentrations, which were significantly 
decreased by atropine 1μM. In addition, in isolated mesenteric rings, diosgenin induced 
marked increase in nitric oxide (NO) levels, which was completely abolished after functional 
endothelium removal. The results obtained here demonstrated that diosgenin-induced 
relaxation appears to involve endothelial muscarinic receptor activation with increase in 
intracellular calcium concentrations and consequent release of endothelium-derived relaxing 
factors (EDRFs), mainly NO and cyclo-oxygenase derivatives, which activate BKCa channels.  
Nevertheless, further studies are necessary to clearly elucidate residual endothelium-
independent relaxation induced by diosgenin. 
EC 50= Half maximal effective concentration; Concentration of a drug which induces a 
response halfway between baseline and maximum. 
Emax= The concentration required to produce maximum effect. 
mM= Millimolar concentration 
µM= Micromolar concentration 
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nM= Nanomolar concentration 
FURA-2= This is a ratiometric fluorescent dye which binds to free intracellular calcium. 
 
TOXICOLOGY 
1. Upon intravenous injection saponin glycosides causes hemolysis( phytotherapies.org ). 
2. Weak diarrhoea is being reported in some cases that is why the person having week 
digestion should use it carefully( phytotherapies.org). 
3. Dioscorea is generally considered safe in all trimesters of pregnancy and is 
traditionally indicated for nausea of pregnancy (McIntyre, A. 1995), and for 





The activity of Dioscorea floribunda has been attributed to the action of various steroidal 
saponins (diosgenin an aglycon). 
 ANTITUSSIVE EFFECTS 
Dioscorea floribunda extract suppresses cough reflexes (Phytotherapies.org) this 
theory reinforces traditional usage of Dioscorea floribunda as antitussive in Pakistan. 
 VASORELAXATORY EFFECTS 
Diosgenin has shown vasorelaxant effect in the studies done, on endothelial cells 
isolated from rat superior mesenteric artery, by (Dias, Correia et al. 2007). It was 
demonstrated that diosgenin induces vasorelaxation in an endothelium dependent 
manner. Endothelium dependent relaxatory effects is mediated through (BKCa) 
channels, also involves NO/ CGMP pathway, and is significantly inhibited by pre-
treatment with (BKCa) channels inhibitors. This effect was completely abolished by 
removal of endothelium. 
Increase in the intracellular calcium levels regulates the activity of endothelial NOS 
and neuronal NOS isozymes that produce NO (nitric oxide) in vessels and neurons, 
respectively (Lopez-Ramos et al. 2005). In primary culture of endothelia mesenteric 
cells, diosgenin and acetylcholine induced an increase in the intracellular calcium 
levels and this effect was significantly abolished after atropine (1µM) administration, 
suggesting that the increase in the intracellular calcium levels are probably due to 
muscarinic receptor activation present in endothelial cells. 
In conclusion it has been demonstrated in the work done by the studies named above 
that EDRFs (mainly NO and COX derivatives) and activation of (BKCa) channels play 
a major role in the vasorelaxation induced by diosgenin in rat superior mesenteric 
artery. Nevertheless, further studies are necessary to clearly elucidate the residual 




 ANTI-INFLAMMATORY EFFECTS 
There is no doubt that the phytosterols (of which diosgenin is a member) will give 
soothing and anti-inflammatory effect to the extract and so be a very useful topical 
additive to a skin cream for mature and dry skin types. This is being borne out in some 
of the latest studies being published on Wild Yam extracts targeted at the skin care 
formulator (Anthony C. et. al, 2002). 
 ANTI-RHEUMATIC EFFECTS 
Steroidal nature of diosgenin justifies the use of Dioscorea floribunda along with 
other Dioscorea species in England against rheumatism related inflammation and pain 
(Anthony C. et al 2002). 
 
 ANTI-CANCER EFFECTS 
(Chiang, Way et al. 2007) demonstrated the effects of Dioscorea floribunda extract on 
HER2 expressing tumors but further studies should be done to find out either this 
activity could be used as adjuvant to modern treatment methods. 
 
 COMMERCIAL SYNTHESIS OF STEROIDS 
Sugar free aglycon; Diosgenin derived from Dioscorea floribunda and other members 
in the Dioscoreacea family can be used as a starting material in the production of 
steroids( like cortisone, pregnenolone and progesterone as studied by (Marker and 
Krueger 1940). 
 COSMETIC USES 
Anticollagenase effects induced by diosgenin as studied by (Liviero and Allec 2002) 
and usage in facial and neck cosmetics for anti aging as described by (Liviero and 
Allec 2002) and anti-wrinkle treatment(Besne 2003) and face lift(Eymard M, 2004) 
clearly gives scientific basis for anti-aging effects and traditional usage of Dioscorea 
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BOTANICAL NAME:-Citrullus colocynthis (L.) schrad. 
ENGLISH NAME: - COLOCYNTH 
URDU/ LOCAL NAME: - Korhtumma 
FAMILY: - Cucurbitaceae 
 
PARTS OF PLANT USED:- 
Dried fruit pulp, leaves. 
 
ETHNOPHARMACOLOGY 
USES IN PAKISTAN 
 
 CATHARTIC 
 TREATMENT OF PARASITIC DISEASES IN LIVSTOCK 
(Farooq, Iqbal et al. 2008), (Jabbar, Raza Muhammad et al. 2006) 
 
 
USES IN UAE( United Arab Emirates) 
 
 Diabetes (Al-Ghaithi, El-Ridi et al. 2004) 
USES IN AFRICA (Nigeria) 
For the treatment of sick camels(Antoine-Moussiaux, Faye et al. 2007). 
 
USES IN USA 
Citrullus colocynthis extract has been used in a topical preparation for the treatment of dermal 
abrasions in animals to avoid licking of wound. 
(Berdami 2001) described usage of Citrullus colocynthis in a topical preparation, being used 
in the United States of America for epidermal abrasions, as bitter principle to avoid pets from 
licking wounds. This topical preparation contains Citrullus colocynthis powder 2-5 gram 
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along with other ingredients including bacitracin zinc 300 neomycin 35, polymyxin-B sulfate 
10,000 mg, and pramoxine-HCl 10 mg. White petroleum jelly is used as a solvent and carrier 
for the active ingredients.  
USES IN IRAN 
 Abortifacient 
 Treatment of constipation 
 Edema 
 Bacterial infections 
 Cancer 
 Diabetes 




(Tannin-Spitz, Grossman et al. 2007).(Tannin-Spitz, Bergman et al. 2007),  
(S, E. Adam, et al. 2001) 
Citrullus colocynthis extract contain:-  
 Cucurbitacin A 
 Cucurbitacin B 
 Cucurbitacin C 
 Cucurbitacin D 






Fig. Chemical structure of Cucurbitacin B glycoside (MW = 739). Structure of Cucurbitacin E 
glycoside (MW = 737) is the same as Cucurbitacin B glycoside except for a double bond 
between carbons 1 and 2 (MW= Molecular weight). 
(Delazar, Gibbons et al. 2006) isolated following two Cucurbitacin glycosides from the 
Citrullus colocynthis extract:- 
4. 2-O-beta -D-glucopyranosylcucurbitacin I 
5. 2-O-beta -D-glucopyranosylcucurbitacin L 
FLAVONOIDS 
 
(Delazar, Gibbons et al. 2006) isolated 3 flavonoids and two Cucurbitacin glycosides (given 




3. Isoorientin 3`-O-Methyl ether 
1-3 have shown significant antioxidant properties. 
 
 
MATERIALS AND METHODS 
The reversed-phase preparative HPLC was employed to isolate compounds from the butanol 
fraction of the hydro-methanolic (70%) extract of the fruits of the locally grown Citrullus 
colocynthis. Structures of the isolated compounds [1-5] were elucidated by spectroscopic 
means. Three flavones glycosides, Isosaponarin [1], Isovitexin [2] and Isoorientin 3'-O-Me 
ether [3] and two Cucurbitacin glycosides, 2-O-beta -D-glucopyranosylcucurbitacin I [4] and 
2-O-beta -D-glucopyranosylcucurbitacin L [5] were isolated and identified. 
ASCORBIC ACID CONTENT 
(Hussain, Khan et al. 2008) determined Vitamin C content of Citrullus colocynthis to be 





1. ANTI-DIABETIC EFFECTS 
(Sangameswaran, Balakrishnan et al. 2008) proved the hypoglycemic effects of Citrullus 
colocynthis on alloxan induced diabetic rats in the following study:- 
AIM OF THE STUDY 
This study was designed to investigate the anti-hyperglycemic effect of leaves of Citrullus 
colocynthis (Cucurbitaceae) in normal and alloxan induced diabetic rats.  
Diabetes was induced in adult Male rats of Wistar strain, weighing 150-200g by 
administration of alloxan (150 mg/kg body wt.) i.p (Intraperitoneally). Diabetic rats showed 
an increase in levels of blood glucose.  
 The methanolic and aqueous extracts of Citrullus colocynthis were given to the experimental 
group for a period of 12 days. Citrullus colocynthis extracts showed significant hypoglycemic 
activity in experimental rats as compared with the diabetic control group in a 12 days study. 
The anti-diabetic activity was also compared with the standard anti-diabetic agent, 
glibenclamide (500micro g/kg). The result indicates that methanol and aqueous extracts 
showed significant (P<0.01) anti-diabetic activity when compared with standard and diabetic 
control.  
 
2. ANTIOXIDANT EFFECT 
(Delazar, Gibbons et al. 2006) isolated 3 different flavonoids from the  
Citrullus colocynthis extract i-Isosaponarin, ii- Isovitexin and  
iii- Isoorientin 3`-O-Methyl ether. All of them exhibited significant anti-oxidant effect in 2, 2-
diphenyl-1-picrylhydrazyl (DPPH) assay. 
3. ANTI-CANCER( CYTOTOXIC) EFFECTS  
(Tannin-Spitz, Grossman et al. 2007) studied the effect of Citrullus colocynthis plant on 
human breast cell cancer in the laboratory studies as follows:- 
 
AIM OF THE STUDY 
Aim of the study was to study the effects of Cucurbitacin glycosides extracted from  
Citrullus colocynthis leaves on human breast cancer cell growth. 
 Leaves were extracted, resulting in the identification of Cucurbitacin B/E glycosides.  
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The Cucurbitacin glycoside combination (1:1) inhibited growth of ER+ MCF-7 and  
ER_ MDA-MB-231 human breast cancer cell lines. 
Cell-cycle analysis showed that treatment with isolated Cucurbitacin glycoside combination 
resulted in accumulation of cells at the G2/M phase of the cell cycle. Treated cells showed 
rapid reduction in the level of the key protein complex necessary to the regulation of G2 exit 
and initiation of mitosis, namely the p34CDC2/cyclin B1 complex.  
Cucurbitacin glycoside treatment also caused changes in the overall cell morphology from an 
elongated form to a round-shaped cell, which indicates that Cucurbitacin treatment caused 
impairment of actin filament organization. This profound morphological change might also 
influence intracellular signaling by molecules such as PKB, resulting in inhibition in the 
transmission of survival signals.  
Reduction in PKB phosphorylation and inhibition of survivin, an antiapoptosis family 
member, was observed. 
 The treatment caused elevation in p-STAT3 and in p21WAF, proven to be a STAT3 positive 
target in absence of survival signals. Cucurbitacin glycoside treatment also induced apoptosis, 
as measured by Annexin V/propidium iodide staining and by changes in mitochondrial 
membrane potential (DC) using a fluorescent dye, JC-1.  
These facts indicates that Cucurbitacin glycosides exhibit pleiotropic effects on cells, causing 
both cell cycle arrest and apoptosis. These results suggest that Cucurbitacin glycosides might 
have therapeutic value against breast cancer cells. 
___________________________________________________________________ 
PKB= Protein kinase B 
Pleiotropiy= The quality of a gene to manifest itself in more than one way i.e. to produce 
more than one phenotypic expression. 
 
4. ANTI-PARASITAL EFFECTS 
(Farooq, Iqbal et al. 2008) described anti-parasital effects of Citrullus colocynthis in the 
following study on livestock in Pakistan. 
 
AIM OF THE STUDY 
 This study was conducted to document the ethno veterinary medicinal (EVM) practices for 
the treatment of different parasitic diseases of livestock in Cholistan desert, Pakistan.  
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MATERIALS AND METHODS 
 An initial reconnaissance survey (rapid rural appraisal) among the local shepherds was 
conducted to identify the traditional healers. Information was collected from the traditional 
healers using a well-structured questionnaire through open-ended interviews and guided 
dialogue technique.  
RESULTS 
The parasitic diseases reported in livestock were: 
(i)-  Tick and lice infestation 
(ii)  Mange 
(iii) Myiasis; a condition caused by infestation of the body by fly maggots.  
(iv) Helminthiasis. 
 A total of 77 ethno veterinary practices comprising of 49 based on plant usage and 28 based 
on dairy products, chemicals and other organic matter were documented. A total of 18 plant 
species representing 14 families were documented to treat the parasitic diseases.  
The plants included: Citrullus colocynthis (Cucurbitaceae), Aerva javanica (Amaranthaceae), 
Aizoon carariense (Aizoaceae), Azadirachta indica (Meliaceae), Brassica campestris 
(Cruciferae), Capparis decidua (Capparaceae), Capsicum annuum (Solanaceae), Cyperus 
rotundus (Cyperaceae), Calligonum polygonoides (Polygonaceae), Eruca sativa (Cruciferae), 
Ferula assafoetida (Umbelliferae), Haloxylon salicornicum (Chenopodiaceae), Mallotus 
philippinensis (Euphorbiaceae), Nicotiana tabacum (Solanaceae), Pinus roxburghii 
(Pinaceae), Salsola baryosma (Chenopodiaceae), Solanum surratens (Solanaceae) and 
Zingiber officinale (Zingiberaceae). 
 
(Jabbar, Raza Muhammad et al. 2006) surveyed in southern Punjab, Pakistan, in order to 
document existing ethnobotanical knowledge by the herdsmen/key respondents about 
anthelmentic in ruminants. A 3 stage process was used to document the plants being used to 
treat and/or control helminthes. This study describes 29 plants to treat helminthiais in 
ruminants. The main plants used were Citrullus colocynthis (L.), Lamium amplexicaule L., 
Mallotus philippinensis Muell, Withania somnifera (L.) Dunal, Azadirachta indica.  
A few of these plants have been scientifically validated for their claim by herdsmen on 





(Adam, Al-Farhan et al. 2000) described the toxicological properties of Citrullus colocynthis 
and a few other plants in the following study:- 
MATERALS AND METHOD 
The effect of oral administration of 0.25 g/kg/day of Citrullus colocynthis fruits,  
0.25 g/kg/day of Rhazya stricta leaves or mixture of the two plants at 0.25 g/kg/day of 
Citrullus colocynthis fruits plus 0.25 g/kg/day of Rhazya stricta leaves in Najdi sheep was 
examined. Oral administration of 0.25 g/kg/day of Citrullus colocynthis fruits or 0.25 
g/kg/day of Rhazya stricta leaves for 42 days proved not fatal but that of the mixture of the 
two plants (0.25 g + 0.25 g/kg/day) proved fatal within 26 days with profuse diarrhea, 
dehydration, loss in condition, ataxia and recumbency, prior to death. These manifestations 
accompanied by enterohepatonephrotoxicity, gelatinization of the renal and epicardial fat and 
transudate in serous cavities were correlated with alterations in serum LDH and AST 
activities and concentrations of total protein, albumin, globulin, bilirubin, cholesterol and urea 
and hematology.  
These results shows cathartic potential of Citrullus colocynthis and the other herb under study 
Rhazya stricta but the individual effect of both herbs become stronger in combination 
treatment causing diarrhea. 
 
DISCUSSION/ CONCLUSION 
 CATHARTIC EFFECTS 
(Adam, Al-Farhan et al. 2000) demonstrated the cathartic potential of Citrullus colocynthis by 
studies done in sheeps. But the effect on motility of intestine becomes even stronger in the 
presence of Rhazya stricta.  
These findings should be further investigated to find the active principles responsible for 
cathartic effect. However these facts support the traditional usage of Citrullus colocynthis as a 





 ANTI-DIABETIC EFFECTS 
The studies done by (Sangameswaran, Balakrishnan et al. 2008) on rats proved  
Anti-hyperglycemic effects of Citrullus colocynthis extract; which supports the traditional 
usage of Citrullus colocynthis as anti-diabetic agent. But there is need for further research to 
find the active ingredients responsible for this effect.  
A combination of Citrullus colocynthis and the synthetic drugs could also be researched to 
reduce the effective dose of the synthetic drugs hence reducing the side effects and getting 
effective and safe management of diabetes. 
 ANTI-OXIDANT PROPERTIES 
(Delazar, Gibbons et al. 2006) isolated 3 flavonoids from the Citrullus colocynthis extract. 
Since reactive oxygen species are important contributors to tissue injury, inflammation, 
cancer and many other diseases, the antioxidant properties of 3 isolated flavonoids probably 
contribute, at least to some extent, to the pharmacological and traditional uses of Citrullus 
colocynthis. It has been widely accepted that beneficial effects, shown by flavonoids, against 
cancer and heart diseases, is not only due to their antioxidant properties but also by other 
mechanisms.  
 TREATMENT OF BREAST CANCER 
The laboratory study done by (Tannin-Spitz, Grossman et al. 2007) demonstrates the growth 
inhibitory effects of Cucurbitacin B and E on  ER+ MCF-7 and ER_ MDA-MB-231 human 
breast cancer cell lines. These results could be used to design a clinical trial and scientifically 
support the affectivity of this traditional remedy against one of the challenging diseases to 
modern clinical sciences. Citrullus colocynthis extract could lead to production of a 
significant, safe and effective remedy after application of toxicological and clinical 
parameters. It could also become adjuvant to the anti-breast cancer regimens made up of 
synthetic drugs which could helps to lower the side effects. 
 TREATMENT OF PARASITAL DISEASES IN LIVSTOCK 
(Farooq, Iqbal et al. 2008) and (Jabbar, Raza Muhammad et al. 2006) studied the traditional 
usage of Citrullus colocynthis and the other herbs as anti-parasital in livestock, among the 
traditional herbalists in the Pakistan. The traditional usage shows the significance of safe and 
effective usage of Citrullus colocynthis and other plant remedies in the parasital diseases but 
it is needed to design further pharmacological and clinical work, to find the active ingredients 
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responsible for this effect, and determine safe and toxic doses using standard parasitological 
procedures. 
Further the outcomes from the animal studies could be extrapolated to human beings to find 
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BOTANICAL NAME: - Ferula asafoetida (H.Karst.) 
Family: - Umbelliferae 
English name: - Asafetida 
Urdu name: - Hing 
Local name in Pakistan: - Rawe (chitral) Suff (Gilgit)   
Location in Pakistan: - Harchonullah, Bateashi, kamari, mauskhi, Zarghum.   
DISTRIBUTION:- 
The plant grows abundantly on dry exposed steep hill slopes of Harchonullah, near the village 
Batwashi along the road side and near Kamari village 1515 m to 2727 m asl.   
(www.parc.gov.pk/data/medicinal/medsearch.asp/) 
Asafoetida is the oleogum resin obtained by incision of the roots of various plants from the 




1. OLEORESIN EXUDATE, Asafoetida or Asafetida is the dried latex,  
Oleo- gum or oleo- resin exuded from the taproots of perennial herbs belonging to 
many species of the genus Ferula(George 2006). 
2. Dried roots, Crushed roots powder. 
DESCRIPTION 
Asafoetida is the milky juice (latex), which forms a resin, from the root of Ferula asafoetida. 
Asafoetida contains 400-640 g/kg resin, 250 g/kg gum, 100-170 g/kg volatile oil and 15-100 
g/kg ash (7). The chief constituent of oil is secondary butyl prophenyl disulphide(Thyagaraja 
and Hosono 1996) . 
 




USES IN PAKISTAN 
1. Asthma(Damotahi)  
2. Common cold 
3. Coughs 
4.  Kudakan (child disease) 
5.  Toothache  
6. Gastric problems like ulcer. 
7. Constipation(Qabzi)  
8. Arthritis 
9. To prepare cows for mating.  
(www.parc.gov.pk/data/medicinal/medsearch.asp/) 
 
USES IN IRAN 
1. Abdominal pain 
2. Constipation 
3. Diarrhea   
4. Anthelmentic 
USES IN NEPAL 
 Emmenagogue 
 Anthelmentic 
 Aphrodisiac (Eigner et al, 1990) 
 
USES IN UNITED STATES OF AMERICA 









 ANTIFUNGAL (Takeoka 2001) 
Field of usage: - preservation of food. 
USE AS FOOD SPICE 
Asafoetida has a strong, tenacious, sulfurous odor and is an important spice used in 
Indian, European and some Middle Eastern foods(Takeoka 2001). 
CHEMISTRY 
 GUM FRACTION ( Kajimoto, 1989) 
Asafoetida contain 25% gum fraction including glucose, galactose, l-arabinose, 
rhamnose and glucuronic acid.  
 RESIN FRACTION 
Resin fraction comprises 40–64 %( Kajimoto, 1989), which contains ferulic acid esters 
(60%), free ferulic acid(1.3%), coumarin derivatives(e.g. Umbeliferone) and volatile 
oils (3-17%), and monoterpenes. 
 Volatile oil 
Ferula asafoetida yields 3-17% volatile oils on extraction  
 (Kajimoto 1989) (Mahran, El Alfy et al. 1975). 
Volatile oil contains following ingredients:- 
1. Alpha- and beta- pinene  
2. Diallyl sulfate 
3. Diallyl sulfide 
4. Sencondary butyl propenyl disulfide 
5. Secondary butyl propenyl disulfide 
6. Alpha-phellandrene 




 MINERAL COMPOSITION 
Mineral composition is as followed as described by(Uma Pradeep, Geervani et al. 
1993) p.141. 
    mg/100g asafoetida 
 
- Calcium      1007.4 mg/100 g 
- Phosphorus  299.5 mg/ 100 g 
- Iron  59.90 mg/100 g 
-  Manganese 1.63 mg/ 100g 
-  Magnesium 108.9 mg/ 100g 
-  Zinc 0.62 mg/ 100g 
 Starch 19.89 % 
 Proximate composition and energy content of Ferula asafoetida 
 (g/100 g edible portion) 
                        _____________________________________________________________ 
  Energy             Dry matter    Ash       Nitrogen    Protein      Fat         CHO*       
(Kilo calorie)                        
                         _____________________________________________________________ 
     90.76               4.97           0.68           0.68         4.25         2.65        78.89                                                
                        _____________________________________________________________ 





 Dietary fiber, uronic acid, tannins and phytic acid in spices:- 
Dietary fiber 
(%DM) 
IDF  SDF    TF 








1.9   56.42  
58.3 
52.9 11.22 0.80 --- 
 
%DM= Percent dry mass 
IDF= Insoluble dietary fiber 




1. ANTI-FUNGAL EFFECTS 
(Thyagaraja and Hosono 1996)demonstrated that Ferula asafoetida non-aqueous 
extract inhibits significantly the fungi responsible for food spoilage. 
Materials and Methods 
1. Spices 
Spices procured from India, namely chilli, coriander, cumin, pepper, turmeric and 
asafoetida were ground to fine powder in a Warring blender and extracted in 950 g/L 
ethanol. The extract containing 10 mg/ml equivalent of spices was used in an 
inhibition assay. 
2. Moulds and incubation 
The organisms Rhizopus azygosporus (IFO 31989), Mucor dimorphosphorous 
 (IFO 4555), Penicilliumcommune (IFO 5763) and Fusarium solani (IFO 9425), were 
used as indicator organisms. These were selected to represent moulds commonly 
encountered in food spoilage. These fungi were maintained in potat-dextros agar 
medium following recommendations from IFO. 
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3. Inhibition assay 
The assay was carried out by filter disk method (4). The inhibition assay was carried out in 
potato dextrose agar (Oxoid) by the paper disc method. The inoculum (0.1 ml) was transferred 
into a well-dried PDA plate and spread on the surface to make a lawn. After allowing 
sufficient time for absorption of the moisture, a paper disc and 40 ml of spice extract was 
placed in the centre of the agar. The plate was incubated at 25°C and inhibition observed by 
measuring the clear zone around the paper disc. All the assays were carried out in triplicate 
and repeated at least twice (means of two experiments are reported). 
 
In the above study (Thyagaraja and Hosono 1996) demonstrated that it was only Ferula 
asafoetida which inhibited mould growth up to a significant level. 
Further it was found that the active ingredient responsible for mould inhibition is present in 
diethyl-ether extract and aqueous extract obtained by hot water does not have any inhibitory 
activity. 
_______________________________________________________________ 
IFO= (Institute of Fermentation, Osaka, Japan) 
 
2. ANTI-SPASMODIC EFFECTS 
(Fatehi, Farifteh et al. 2004) demonstrated anti-spasmodic effects of Ferula asafoetida 
gum extract on Guinea-pig ileum and blood pressure on anesthetized rats in the 
following experiment:-  
 
              EFFECT ON PRE-CONTRACTED GUINEA PIG ILEUM  
 The effects of Ferula asafoetida gum extract on the contractile responses of the 
isolated guinea-pig ileum induced by acetylcholine, histamine and KCl and on the 
mean arterial blood pressure of rat were investigated. In the presence of Ferula 
asafetida extract (3 mg/ml), the average amplitude of spontaneous contractions of the 
isolated guinea-pig ileum was decreased to 54 +/- 7% of control.  
Exposure of the pre-contracted ileum by acetylcholine (10 µM) to Ferula asafoetida gum 
extract caused relaxation in a concentration-dependent manner.  
Similar relaxatory effect of the extract was observed on the pre-contracted ileum by histamine 
(10 µM) and KCl (28 mM). However, when the preparations were pre-incubated with 
indomethacin (100 nM) and different antagonists, such as propranolol (1 µM), 
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atropine (100 nM), and chlorpheniramine (25 nM) then were contracted with KCl, 
exposure to the extract (3 mg/ml) did not cause any relaxation. 
_____________________________________________________________________ 
µM= micro molar concentration. 
 
EFFECT ON BLOOD PRESSURE OF ANESTHESIZED RATS 
 Furthermore, Ferula asafoetida gum extract (0.3-2.2 mg/100g body weight) significantly 
reduced the mean arterial blood pressure in anaesthetized rats. It might be concluded 
that the relaxant compounds in Ferula asafoetida gum extract interfere with a variety 
of muscarinic, adrenergic and histaminic receptor activities or with the mobilization of 
calcium ions required for smooth muscle contraction non-specifically.  
 
 
3. ANTIOXIDANT ACTIVITY    
  (Sujatha and Srinivas 1995)  Studied the antioxidant effects of a number of Indian 
plants including Ferula asafoetida and demonstrated that ferula asafoetida has a 
significant antioxidant effect. 
 MATERIALS AND METHODS 
The following materials were used in this research:- 
 
1. Bovine serum albumin 
2. Nitroblue tetrazolium (NBT) 
3. Superoxide dismutase (SOD) 
4. 12-0-tetradecanoyl phorbol-13-acetate (TPA) 
5. Tert-butyl hydroperoxide (tBHP) 
6. Butylated hydroxyanisole (BHA)  
7. Curcumin was purchased from Sigma Chemicals (St Louis, MO, USA). 
8. Ferrous sulfate 
9. Ascorbic acid  
10. Hanks‘ balanced salt solution was purchased from Himedia Private Ltd (India). 
11. Thiobarbituric acid was purchased from Loba Chemie (India). 
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 All other chemicals and reagents were of Analar grade and were purchased from Glindia 
Laboratories (India). Solvents were distilled before use and were peroxide free. 
 
Erythrocyte ghosts were prepared by hypotonic lyses of human blood according to the 
procedure of Dodge et al. (1963). The SOD was removed by washing the pellets thoroughly 
with isotonic saline. Protein was estimated according to the method of Spector (1978). The 
ghost suspension, containing 3OOµg protein, was subjected to peroxidation induced by 
exposure to ferrous sulfate-ascorbate (10:lOOµmol) for 20min at 37°C according to the 
Procedure of Shimasaki et al. (1984). 
 
Lipid peroxidation was estimated in terms of thiobarbituric acid reactive substances (TBARs) 
at 535 nm using a Shimadzu Spectrophotometer.  
Conjugated dienes were also estimated as a sensitive index of lipid peroxidation, according to 
the method of Stoffel and Ahrens (1958). The membrane lipids, after peroxidation were 
extracted with chloroform- methanol (2: I, v/v), evaporated under nitrogen, and redissolved in 
hexane. The absorbance spectra were recorded at 200-320 nm.  
 
 
Studies on the prevention of peroxidation were carried out using antioxidants such as BHA, 
Curcumin and fresh aqueous extracts of spices and vegetables. Appropriate blanks and 
controls were included along with the test samples to take into account any non-specific 
contribution to the final chromophore or interference with the assay. The concentration of 
standard antioxidants used was based on the literature. 
 
Aqueous extracts of spices were prepared by adding 50 mg of the powdered spices to 5 ml 
boiling distilled water. The mixture was vortex mixed and centrifuged (I 500 rpm, 15 min, 
25°C). Known volumes were taken from the clear supernatant for the assay.  
To prepare the vegetable extracts, I g of vegetable was finely chopped and crushed in a glass 
pestle and mortar, and then 5 ml boiling distilled water was added and the fresh extracts 
containing known amounts of solubles were used for the inhibition assays. Boiling water was 
used to destroy vitamin C; the known antioxidant in vegetables to improve the solubility and 
to simulate the culinary (something related to kitchen) practices that are usually followed. 
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 The extracts alone were used as blanks, and any interference in the chromophore formation 
was taken into account. The residue after extraction was weighed to calculate the solubility 
(Salimath et al., 1986). 
 
Lipid peroxides were prepared by subjecting the human erythrocyte membrane (300 µg 
protein) to peroxidation by exposure to ferrous sulfateascorbate (10: I00 µmol) for 20 min at 
37°C. The peroxidized lipid was extracted with 5 ml ethanol-diethyl ether (3: 1, v/v), 
evaporated under nitrogen and suspended in 2 ml 0.9% saline (Frankel et al., 1987).  
50µ1 of the extract was equivalent to 1.75 nM malondialdehyde (MDA)/mg protein.  
Lipid peroxide-induced membrane lysis was studied using human erythrocytes as the model 
system by monitoring the release of haemoglobin due to haemolysis, according to the 
procedure of Mack et al. (1972). 1 ml freshly drawn human blood was diluted immediately 
with 9 ml 0.9% saline and centrifuged at 1500 rpm for 10 min at 25°C. The pellets were 
washed twice with 0.9% saline and resuspended in 7.5 ml 0.9% saline. I ml of the erythrocyte 
suspension was incubated with lipid peroxides in the presence and absence of aqueous 
extracts of spices in a total volume of 5 ml 0.54% saline. Incubation was carried out for 20 
min at 37ºC, at the end of which the solution was centrifuged at 1500 rpm and the optical 
densities of the supernatants at 540nm were measured.  
 
Human PMNLs were used as another model system to investigate lipid peroxide-mediated 
membrane events. The possible prevention of lipid peroxidation by aqueous extracts of spices 
was also carried out.  
 
RESULTS 
Lipid peroxidation of erythrocyte membrane: effect of aqueous extract of spices 
Aqueous extracts of spices were tested for their antioxidant activity and compared with the 
known antioxidants BHA and Curcumin. In the presence of BHA (400 µM) and Curcumin 
(400µ M) there was 77 and 68% inhibition, respectively. 






BHA = butylated hydroxyanisole; 
BHT = butylated hydroxytoluene; 
fMLP = formyl methionyl _ leucinyl -phenylalanine; 
MDA = malondialdehyde: 
NBT = nitroblue tetrazolium; 
 PMNL = polymorphonuclear leucocyte; 
 SOD = superoxide dismutase; 
TBars = thiobarbituric acid reactive substances. 
nM= nano molar concentration. 
tBHP = tertiary-butylhydroperoxide. 





(Leung et al, 1980) Ferula asafoetida gum has anti-coagulant activity. 
 
5. MOLLUSCICIDAL ACTIVITY 
(Kumar and Singh 2006) demonstrated effect of dried root latex powder of Ferula 
asafetida in fascioliasis caused by a snail Lymnaea acuminata; the intermediate host 
of which causes endemic fascioliasis in the cattle population of northern India. 
  
The molluscicidal activity of dried root latex powder of Ferula asafoetida, flower-bud powder 
of Syzygium aromaticum, and seed powder of Carum carvi against the snail Lymnae 
acuminata was studied. The molluscicidal activity of all these 
            3 plant products were both time and concentration dependent. The toxicity of 
Syzygium aromaticum flower-bud powder (96 h LC50:51.98 mg/L) was more 
pronounced than that of root latex powder of Ferula asafoetida (96 h LC50:82.71 
mg/L) and seed powder of Carum carvi (96 h LC50:140.58 mg/L). Ethanol extract 
was more toxic than other organic extracts. The ethanol extract of Syzygium 
aromaticum (24 h LC50:83.53 mg/L) was more effective than that of Ferula 
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asafoetida (24 h LC50:132.31 mg/L) and Carum carvi (24 h LC50:130.61 mg/L) in 
killing the test animals. The 96 h LC50 of column purified fraction of seed powder of 
Carum carvi was 5.40 mg/L whereas those of flower-bud powder of Syzygium 
aromaticum and dried root latex powder of Ferula asafoetida were 7.87 and 9.67 
mg/L, resp. The product of Ferula asafoetida, Syzygium aromaticum, and Carum carvi 
may be used as potent molluscicides.  
6. ANTI-ULCER EFFECTS 
(Rao, Kumar et al. 2007) described a novel herbal remedy for the treatment of Gastric 
ulcer; this contains Ferula asafoetida and a number of other herbal ingredients. These 
findings in this study support traditional usage as an anti-ulcer herb. 
7. ANTI-TRICHOMONAS VAGINALIS EFFECT 
(Ramadan Nashwa and Al Khadrawy Faisal 2003) studied the effect of oleo-gum resin 
from Ferula asafoetida on growth of Trichomonas vaginalis in vitro. Ferula 
asafoetida gum exhibited inhibitory effect on Trichomonas vaginalis. In this study a 
comparison was done to compare the effectiveness of gum obtained from Ferula 
asafoetida with standard synthetic compound Metronidazol as a reference drug. Gum 
Ferula asafoetida showed potent anti-parasitic effect on Trichomonas vaginalis as 
compared to Metronidazol. 





Higher doses taken orally cause diarrhea, meteorism, headaches, dizziness, and 





 ANTI-SPASMODIC AND BLOOD PRESSURE LOWERING EFFECT 
(Fatehi, Farifteh et al. 2004)experimentally determined that Ferula asafoetida has 
relaxant effect on contracted (contraction induced by Acetylcholine, histamine and 
KCl) gastric smooth muscles, in dose dependent manner, in Guinea pig ileum and 
vascular smooth muscles in anesthetized rats.  
The exact mechanism of action is not known but a few hypotheses could be derived 
following the observations done in this study:- 
● Contraction of gastric muscles involves cycles of depolarization and repolarization 
involving influx of calcium Ca+ ions through voltage activated channels (Walsh and Singer, 
1980; Branding, 1981). Therefore extract of gum Ferula asafoetida, may contain a few 
substances, which interfere with contractions induced by calcium channels. 
 
● The contractions produced by acetylcholine are mediated through muscarinic 
receptor sub-type M3 and the guinea pig ileum may have a preponderance of M2 sub-
type muscarinic binding sites, these facts indicate that Ferula asafoetida may interfere 
with muscarinic receptors to counteract contractions produced by acetylcholine. 
● The relaxatory/ reparatory effect produced in the histamine pretreated ileum is 
greater that with Acetylcholine pre treated ileum.  
● The contraction induced by KCl is due to an increase in K+ and depolarization of 
Smooth muscle fibers, leading to increased influx of calcium through L-type voltage-operated 
channels (Gilani et al,. 1994). 
 
However, the spasmolytic activity of the extract could not be attributed solely to any pure 
antagonistic effect, since the tissue contracted by KCl (Potassium chloride) was also relaxed 
after exposure to the extract.  
Considering lack of the relaxatory effect of the extract in the presence of atropine, 
chlorpheniramine and propranolol, one might suggest that these antagonists competed with 
the relaxant compounds of the extract for binding to their acceptors. Therefore, there is no 
good reason to exclude any interaction between some compounds of the extract and 
cholinergic, histaminergic and adrenergic receptors. On the other hand, smooth muscle 
contractile tone can be relaxed by increased levels of 3, 5-cyclic adenosine monophosphate 
(cAMP) (Berridge, 1975). Therefore, the extract may have its relaxatory effect through an 
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increase in cAMP independent of any specific receptor activity, then a reduction in Ca2+ 
levels. The relaxatory effects of the Ferula asafoetida gum extract on vascular smooth muscle 
as well as on ileum smooth muscle may suggest that, this natural product reduce the cytosolic 
Ca2+ in a non-specific manner. 
 
There need for further research  to find out the exact mechanism, however these 
findings scientifically supports the traditional usage of Ferula asafoetida gum for 
abdominal pain and blood pressure. 
 
 ANTIOXIDANT ACTITITY 
Study done by (Sujatha and Srinivas 1995)for antioxidant effect of 
 Ferula asafoetida gum extract in vitro studies using human erythrocytes, 
demonstrated clearly a significant anti-oxidant activity induced by Ferula asafoetida. 
Further Ferula asafoetida inhibited the effect of peroxidases at a significant level as 
compared to the other herbs under study. 
Inhibition of conjugated dienes (a sensitive indicator of peroxidation) by Ferula asafoetida 
and other herbs under study demonstrated that diene conjugation inhibition was more 
effectively done by these herbs under study as compared to α-tocopherol chain breaker in free 
radical reaction. This indicates that anti-oxidant effect exhibited by these herbs under study is 
not only done by chain breaking but also effectively done by either quenching the free 
radicals, scavenging the radicals, or reacting with radicals and thus sparing the targets, or by 
transforming them into non-reactive products or by chelating the metal ions that catalyze the 
free-radical reaction (Halliwell and Gutteridge, 1990). 
 
In the light of said study it is needed to do further research to find out the active ingredients 
responsible for this effect. 
 
However these findings may provide scientific support for the traditional usage of Ferula 





 ANTI-PARASITAL EFFECTS 
           (Ramadan Nashwa and Al Khadrawy Faisal 2003) demonstrated that ole-gum resin 
obtained from Ferula asafoetida has potent inhibitory effect on the growth of an 
anaerobic parasite Trichomonas vaginalis, causing vaginitis in women, in invitro 
study. Further it was found that the effect presented by Ferula asafoetida gum is 
stronger than the reference drug Metronidazol. This finding could be researched 
further by designing clinical trials and may provide safe and effective herbal remedy 
against vaginitis, which could also help in the parasites resistant to the effect of 
Metronidazol.  
Further the anti-parasital effect could be tested on other types of parasites.  
 
 ANTI-FUNGAL EFFECT 
 
The study done by (Thyagaraja and Hosono 1996) clearly demonstrated the anti-
fungal effect of Ferula asafoetida, but it is necessary to research further to isolate the 
active ingredient responsible for this effect. The anti-fungal effect could also be tested 
in the fungi causing diseases in human beings like athlete‘s foot and vaginal 
candidiasis. 
 MOLLUSCICIDAL EFFECT 
(Kumar and Singh 2006) demonstrated the molluscicidal effect, of Ferula asafetida and 
two other plant species, by doing laboratory tests on Lymnae acuminate. This work 
supports the traditional usage of Ferula asafetida and the other plant species under test. It 
is more environment friendly and cost effective to use herbs than the synthetic drugs in 
order to avoid the side effects related to synthetic therapy. It also a matter of facet that the 
farmers living in the rural areas can‘t afford the costs associated with synthetic therapy. 
 
 GASTRIC ULCER 
(Rao, Kumar et al. 2007) described a novel herbal remedy for the treatment of Gastric ulcer 
containing Ferula asafoetida and  a number of other plants are used like , Speragus 
racemosus, Glycyrrhiza glabra, Seaamum indicum, Musa sapientum and 
Trachyaparmum roxburghicinum and optionally, powdered plant parts of Cyclea  
peltate, Embelia ribes, Coriandrum sativum Ferula asafoetida, Aloe barbadensis and 
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Evolvulus aisinodes. These ingredients used in powder form synergize the effects of 
each other. This study supports the traditional usage of ferula asafoetida as anti-ulcer 
herb. 
(Uma pardeep et al, 1993p.141) described that Ferula asafoetida contain about 
10 mg/g herb; It is known that calcium has an acid neutralizing ability that may further 
explain anti-ulcer effect. 
  ANTI- ASTMA,  COUGH SUPPRESSENT 
There is not found any scientific study which could support the traditional usage of 
Ferula asafoetida against asthma and as expectorant in Pakistan and other countries 
but the study done by (Fatehi, Farifteh et al. 2004) for relaxant effects of ferula 
asafoetida on intestinal smooth muscles opens  the possibility of relaxant effects on 
bronchial smooth muscles, there is need for a research trial on the bronchial smooth 
muscles find the scientific basis for the traditional usage of Ferula asafoetida as anti-
asthmatic and cough suppressant. 
 ANTI-CONSTIPATION EFFECT 
There are not found any study which could give scientific support to the traditional 
usage of ferula asafoetida against constipation but the study done by (Uma pardeep et 
al 1993p.141) describes that Ferula asafoetida contain 52.09% fibers; fibers has a 
known stimulatory effect on the intestines this could explain anti-constipation effect of 
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BOTANICAL NAME: - Caesalpinia crista (Linn) 
LOCAL NAME: - Ka-lain in Myanmar, Bagore in Indonesia, Taepee in Thailand, 
nantenkadsura in Japanese and Letkanta in Bangladesh. 
SYNONYMS: - Caesalpinia nuga (L). 
(Kinoshita, Haga et al. 2005) 
FAMILY: - Caesalpinaceae 
 
 
PARTS OF PLANT USED:- 
Leaves, flowers, fruit, root, bark, seeds. 
 
DESCRIPTION (Indian medicinal plants volume II p. 842) 
Caesalpinia crista plant is an extensive climber; branches finely grey-downy, armed with 
hooked and straight hard yellow prickles.  
Leaves 36-60 cm long; petioles prickly; stipules a pair of reduced pinnae at the base of leaf 
each furnished with a long mucronate point; pinnae 6-8 pairs, 5-7.5 cm. long, with a pair of 
hook stipulary spines a the base. 
Leaflets 6-9 pairs, 2-3.8 by 1.3-2.2 cm., membranous, elliptic-oblong, obtuse, strongly 
mucronate, glabrous above, more or less puberulous beneath; petiolules very short; stipels of 
short hooked spines.  
Flowers in dense (usually spicate) long-peduncled terminal and supraaxillary racemes dense 
at the top, lax downwards, 15-25 cm. long; pedicles very short in bud, elongating to 5 mm. in 
flower   and 8 mm. in fruit, brown-downy; bracts squarrose, linear, acute, reaching 1 cm. long, 
fulvous-hairy. Calyx 6-8 mm. long, fulvous-hairy; lobes obviate-oblong, obtuse.  
Petals oblancolate, yellow. Filaments declinate, flattened at the base, clothed with long white 
silky hairs. Pods shortly stalked oblong, 5-7.5 by 4.5 cm, densely armed on the faces with 
wiry prickles. Seeds 1-2, oblong, lead-colored, 1.3 cm. long. 
 
DISTRIBUTION 






USES IN PAKISTAN AND INDIA 
ROOT 
1. ANTI-TUMOR 
The root bark is good for tumors and for removing the placenta. The sprouts are useful 
in the treatment of tumors. 
2. ANTHELMINTIC 
3. ELEPHANTIASIS: - An infectious disease marked by inflammation and obstruction 
of lymphatic‘s and hypertrophy of the skin and subcutaneous tissues, chiefly affecting 
the legs and genitalia. or 
 Hypertrophy and thickening of the tissues from any cause. Elephantiasis is usually 
seen in tropics. 
4. SMALL POX 
FLOWER 
Flower is bitter and heating to body. 
5. DEODORANT; destroys the bad odor due to perspiration. 
6. KAPHA AND VATA;  
7. ASCITES ; Flower ash is used   
 
FRUIT 
The fruit is acrid (Scarp, bitter), heating to the body. 
8. ASTRINGENT TO THE BOWELS 
9. APHRODISIAC 
10. ANTHELMINTIC, in the countries including Myanmar. 








SEED   
The seed is hot and dry 
16. STYPTIC 
17. ANTIPERIODIC 
18. ANTHELMINTIC, also in Myanmar. 




23. HYDROCELE; In Madras India, Pakistan and Madagascar an ointment is being made 
from the powdered seeds with castor oil and applied externally in hydrocele and 
orchitis. 
24. SKIN DISEASES 
25. LEPROSY ( In the unani system) 
26. ANTI-PERIODIC 
27. ANTI-PYRETIC; Valuable in all ordinary cases of simple, continued and intermittent 
fevers. (Also in Myanmar) 
28. TONIC; in Madagascar and Indonesia 
29. FEBRIFUGE; in Madagascar 
30. BLENNORRHAGIA; in Madagascar  
31. ASTMA; Have been found useful in a few cases of asthma. 
32. VESICANT; in Guinea pounded seeds are used 
33. MALARIA; were administered with equal part of pepper powder. But didn‘t proved 
good in Malignant malaria.(Also in Myanmar) 
34. ANTI-BLENNORRHAGIC ; in Madagascar 
35. TOPICAL FORMULATION FOR INFLAMMATION, INFLAMED PILES AND 
ORCHITIS 
The leaves and seeds are roasted with castor oil and are applied externally to 
inflammatory swellings especially to inflamed piles, hydrocele, and orchitis (Koman) 
LEAVES 
36. LIVER DISORDERS; tender leaves are considered very efficacious. 
37. DEOBSTRUENT; In China  
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38. EMMENGOUGE: in China and Madagascar 
39. ANTI-CONVULSENT; an oil expressed from it in China is given in convulsions, 
palsy and similar complaints. 
40. INTERMITTENT FEVERS 
In Malaya the young leaves are used in intermittent fevers, and for expelling intestinal 
worms, also in Ceylon. 
41. TOOTHACHE; In Ceylon 
42. SORE THROAT; the boiled leaves are used as a gargle for sore throat. 
ROOTS 
43. FEBRIFUGE (an herbal remedy which can reduce fever); in Madagascar and Guinea a 
decoction of root is used to reduce the fever. 
44. ANTHELMENTIC;  in Madagascar 
45. LEUCORRHEA; in Madagascar 
46. BLENNORRHAGIA; in Madagascar 
47. ANTI-PYRETIC; in Guinea a decoction of roots is used in fever 









Caesalpinia crista contains two major types of Diterpenes as follows:- 
1. Cassane type Diterpenes(Caesalpins). 
2. Norcassane type Diterpenes(Nor-caesalpins). 
 
                  (Awale, Linn et al. 2006) isolated *10 types of Furano-cassane type diterpenes 
from the CH2Cl2 (Dichloromethane) extract of Caesalpinia crista (from Indonesia) seed 
kernels in the following study. 
MATERIALS AND METHOD 
Air-dried seed kernels of Caesalpinia crista Linn, were extracted with CH2Cl2 by overnight 
percolation at room temperature. The CH2Cl2 extract was then fractionated by silica 
gel column chromatography with a benzene/EtOAc gradient system into nine fractions.  
 
The fractions 6—8 were further subjected to repeated silica gel column chromatography, 
followed by normal- and reversed-phase preparative TLC, to afforded  Caesalpinins H—P 
(1—9) and norcaesalpinin F (10) together with 13 known diterpenes,  Caesalpinin C, 
caesalpinins D, norcaesalpinin E, 2-acetoxyl-3-deacetoxycaesaldekarin e, caesaldekarin e, 
caesalmin E, 1-deacetoxy-1-oxocaesalmin C, 2-acetoxycaesaldekarin e,  3-deacetoxy-6-





1. CASSANE  DITERPENES  (CAESALPINS) 
They are commonly called Furano-cassane-diterpenes but are phytochemically 
classified as Cassane diterpenes. Another synonym name is Caesalpins. 
(C-G) determined by (Linn, Awale et al. 2005) 
                   (H-P) determined by (Awale, Linn et al. 2006) 
● Caesalpinin C: colorless amorphous solid;  
HRFABMS m/z 417.2314 (M + H) + determines the molecular formula  
to be C24 H33 O6. 
● Caesalpinin D: colorless amorphous solid;  
HRFABMS m/z 447.2025 (M +H) + determines the molecular formula  
to be C24 H31 O8. 
● Caesalpinin E: colorless amorphous solid; HRFABMS m/z 463.2317  
(M + H) determines the molecular formula to be C25H35O8. 
   ● Caesalpinin F: colorless amorphous solid; HRFABMS m/z 419.2051   
(M + H)+ determines the molecular formula to be C23 H31 O7. 
 
     ● Caesalpinin G: colorless amorphous solid; HRFABMS m/z 447.2009   
(M + H)+ determines the molecular formula to be C24H31O8. 
 
● CAESALPININ H 
This compound have a molecular formula C22H28O7, can also be chemically 
described as 1-o-deacetyl-caesalpinin D. 
It was isolated as a colorless, amorphous solid. It showed quasimolecular ion at 
m/z 405.1915 (M+H) + in HR-FAB-MS. 
 
● CAESALPININ I 
It was isolated as a colorless amorphous solid and its molecular formula 
C22H26O7 was determined by HR-FAB-MS. 
 
● CAESALPININ J 
It was isolated as colorless amorphous solid with a molecular formula 




● CAESALPININ K 
It was isolated as colorless amorphous solid. The molecular formula was  
C22H32O5 determined by HR-FAB-MS. 
● CAESALPININ L 
HR-FAB-MS of Caesalpinin L (5) showed the Quasimolecular ion at  
m/z 435.2336(M+H) +, consistent with the molecular formula C22H34O7. 
 
● CAESALPININ M  
 
It was isolated as a colorless amorphous solid. The molecular formula 
determined by HR-FAB-MS was C25H34O9. 
 
● CAESALPININ N  
The 13 C NMR spectra resembled with Caesalpinin K (4) but were 
characterized by disappearance of signals due to tertiary methyls with the 
appearance of signals due to an aldehyde group. 
 
● CAESALPININ O 
It was separated as colorless amorphous solid. 
Its molecular formula was determined to be C22 H28 O7 by HR-FAB-MS. 
 
● CAESALPININ P  
It was separated as colorless amorphous solid. 
It showed quasi- molecular ion at m/z 39.12096(M+H) + consistent with the 
molecular formula C22 H30 O6. 
 
2. NOR-CASSANE DITERPENES (NOR-CAESALPINS) 
 
D and E determined by (Linn, Awale et al. 2005) 
F determined by (Awale, Linn et al. 2006) 
 
Norcassane-type diterpenes, named nortaepeenin A–B (Cheenpracha, Srisuwan et al. 2005) 
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               ● NORCAESALPININ A-C (Linn, Awale et al. 2005) 
             ● Norcaesalpinin D: colorless amorphous solid; HRFABMS m/z 477.2106 (M + H) 
+ determines the molecular formula to be C25H33O9. 
 
              ● Norcaesalpinin E: colorless amorphous solid; HRFABMS m/z 377.1946 (M + H) 
+ determines the molecular formula to be C21H29O6. 
 
               ● NOR-CAESALPININ F 
It was isolated as colorless amorphous solid with molecular formula  
C21 H26 O7 as determined by HR-FAB-MS. 
 
              ● NORTAEPEENIN a (C20H26O4) White solid, mp 157–158 ◦C. 
              ● NORTAEPEENIN B (C20H26O5) White solid, mp 145–146 ◦C. 
 
____________________________________________________________ 
*= There was found 20 new Diterpenes from Caesalpinia crista from Myanmar 
(Burma) 
CH2Cl2= Dichloromethane, used as a solvent. 
EtOAc= CH3COOCH2CH= Ethyl acetate 
Quasimolecular ion= A term used to represent a prorogated molecule. 
HR-FAB-MS = High Resolution Fast Atom Bombardment Mass Spectrogram. 




















(Kinoshita, Haga et al. 2005) isolated a new class of chemical compounds from 
Caesalpinia crista extract known as Neocassane diterpenes.  
i) Neocaesalpins H 
ii) Neocaesalpins I 
 
These are characterized by α, β-butenolide hemiacetal ring that is rare in nature.  
They lack 5-hydorxy group which distinguishes them from cassane diterpenes 
(caesalpins). 
 
(i) Neocaesalpins H 
It was isolated as optically active colorless needles, mp 255—256 °C. The molecular 
Formula was deduced as C20H28O5 from the high-resolution mass spectrometry. 
 
The UV absorption maximum at 213 nm along with the IR absorption band at 1738 cm-1 
attested to the presence of an α,β -butenolide ring. 
 























(ii) Neocaesalpins I 
Neocaesalpin I (2) was obtained in optically active colorless fine needles,  
Mp >260 °C.  It had the molecular formula of C20 H26 O4 according to the  
High-resolution mass spectrometry. The acid dehydration of Neocaesalpin H led to 
production of a compound identical in all respects to Neocaesalpin I. 
 
The UV absorption maximum at 277 nm indicated that it had α, β -butenolide ring conjugated 
with one extra double bond. This type of a conjugate α, β -butenolide 




          OTHER CASSANE DITERPENES 
(Cheenpracha, Srisuwan et al. 2005) isolated  nine new Cassane-type diterpenes as follwing:- 
- TAEPEENIN A: - White solid, mp 156–157 ºC, C21H26O3. 
 
- TAEPEENIN B: - White solid, mp 221–222 ºC, C20H24O3. 
 
- TAEPEENIN C: - White solid, mp 154–155 ºC, C21H26O4. 
 
- TAEPEENIN D: - White solid, mp 118.5–119 ºC, C23H28O5. 
 
- TAEPEENIN E: - White solid, mp 57–58 ºC, C21H24O4. 
 
- TAEPEENIN F: - White solid, mp 194–195 8C, C21H26O4. 
 
- TAEPEENIN G: - Viscous oil, C20H32O. 
 
- TAEPEENIN H: - White solid, mp 164.5–165 8C. 
 




were isolated, by various steps process involving extractions and 
chromatography, from the stems and roots of Caesalpinia crista along with 
three known diterpenes: vinhaticoic acid, methyl vinhaticoate and 
ent-11b-hydroxy-rosa-5, 15-diene. Their structures were elucidated on the 
basis of spectroscopic analysis. In addition, the structure of 
Taepeenin A was confirmed by X-ray diffraction analysis. 
 
 PHYTOCHEMICAL ANALYSIS OF  FIXED OIL FROM  
Caesalpinia crista 
(Njoku, Okeke et al. 1999)isolated a fixed oil from Caesalpinia crista in 
the following study:- 
MATERIALS AND METHOD 
Fixed oil were extracted by soxlet from dried seeds, moisture content (5 
%), with petroleum ether (40-60%) and analyzed immediately for iodine 
value, saponification value, refractive index, unsaponifiable matter, acid 
number and peroxide value by AOCS (American Oil Chemists Society) 
methods. Vitamin A and E were quantitatively examined by the method of 
Bassiar, sterol by the method of Stadam, glycolipid was assayed by the 
method of plumber, and phospholipids by the method of Totani et al, 
Gossypol and Mycostoxins were assayed by the method of Leutor et al and 
the official method of AOCS. 
The gum content of the pulverized seeds was determined according to the 
method reported by whistler. The oil was tested for the presence of 
unconventional fatty acids-hydroxy acid using the turbidity test of 
Lakshaninarayana, epoxy and cyclopropane fatty acids by the picric acid 




       Table 1. Proximate analysis of seeds of Caesalpinia crista  
DETERMINATION % YEILD 
Moisture content 14 
Protein 5 
Ash 2 






    Table II. Physicochemical properties of the oil of Caesalpinia crista seed 
DETERMINATION  
COLOR Brown 
% YEILD 10 
STATE AT ROOM 
TEMPERATURE 
LIQUID 
SPECIFIC GRAVITY 0.9200 
REFRECTIVE INDEX AT 30ºC 1.4632 
VISCOSITY 11.05 
ACID VALUE(mg KOH g-1) 3.92 
PEROXIDE VALUE ( meq/l) 2.0 
SAPONIFICATION NUMBER 
 ( mg KOH g-1) 
164 
IODINE VALUE 124 
UNSAPONIFIABLE MATTER 0.7 
GOSSYPOL TRACE 
GLYCOLIPID PRESENT 
TOTAL GUM 23 % 
STEROL PRESENT 
AFLATOXIN B PRESENT 
OCHRATOXIN A PRESENT 







TABLE III. PHYTOCHEMICAL ANALYSIS 
 












      Structural formula of Gossypol , molecular formula C30 H30 O8 (Liang and Wang 2007). 
VITAMIN A PRESENT 
VITAMIN E PRESENT 
CYCLOPROPANE FATTY ACIDS PRESENT 
HYDROXY FATTY ACIDS PRESENT 





CYNOGENIC GLYCOSIDES PRESNET 
TANNINS PRESENT 
ANTHRACENE GLYCOSIDES PRESENT 
CARDIAC GLYCOSIDES PRESENT 
STEROIDAL GLYCOSIDES PRESENT 







1. ANTI-MALARIAL ACTIVITY 
 (Awale, Linn et al. 2006) demonstrated the anti-malarial activities of the 
substances isolated from Caesalpinia crista; Caesalpinins H-P(1-9) and Nor-
Caesalpinins (10) except for 5 were tested for their inhibitory activities against 
growth of Plasmodium falciparum FCR-3/A2 in vitro. All of them displayed 
different potency activity in a dose dependent manner. Among the newly isolated 
compounds, Caesalpinin K and norcaesalpinin F showed the most potent 
inhibitory activity with an IC50 value of 120 and 140 nM., respectively, and were 
less than that reported for a well known antimalarial drug, chloroquine (IC50, 




The IC50 value is defined as that concentration of compound producing 50% growth 
inhibition relative to untreated control. 
nM= nano molar concentration= (10 -6 mol/ Liter)   
 
 
 (Linn, Awale et al. 2005) 
The in vitro studies done by them on Plasmodium falciparum indicates that 
all cassane and Norcassane type diterpenes isolated from the Caesalpinia 
crista plant extract exhibit dose dependent anti-malarial effect but the most 
potent effect was observed in Norcaesalpinin E having IC 50 value 90nM 
(0.090µM), which is significantly stronger than the standard clinical drug 
chloroquine having IC50 value 0.29µM. 
 
 (Kalauni, Awale et al. 2006)studied the anti-malarial effects, against the 
malaria parasite Plasmodium falciparum FCR-3/A2 clone in vitro, of 44 
cassane and Norcassane type diterpenes isolated from Caesalpinia crista of 
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Myanmar and Indonesia; they found that all the isolated diterpenes 
exhibited anti-malarial activity in a dose dependent manner but the most 
stronger antimalarial effect was seen in Norcaesalpinin E with  
IC50 value 0.090 µM, stronger than clinical drug Chloroquine with  




µM= Micro molar concentration 
 
2. TREATMENT OF LEKORRHAGIA(LEUCORRHEA) 
(Duan 2006) described an herbal preparation, for the treatment of Leukorrhagia, 
including Caesalpinia crista 30-60 g and a few other herbs including  Punica 
granatum 80-110 g, Cinnamomum cassia bark 30-60 g, Myristica fragrans seed 30-60 
g, Piper nigrum 30-60 g, Carthamus tinctorius flower 30-60 g and sucrose 800-900 g, 
by the steps of extracting volatile oil from Carthamus tinctorius flower, decocting the 
residue of Carthamus tinctorius flower and the rest ingredients in water, filtering, 
concentrating the filtrate to obtain an extract adding sucrose, granulating, drying, and 
adding the above volatile oil. The inventive granule can be used for the treatment of 
Leukorrhagia, with the advantages of high efficiency, rapid and long-lasting action, 
less toxic and adverse side effects, small volume and convenience for administration, 
storage and transport.  
 
3. ACCELERATION OF FIBULIN-5 PRODUCTION/  ACTIVITY 
 
In a scientific study done by (Ogura, Amano et al. 2006) Caesalpinia crista as a part 
of  composition  accelerates fibulin-5 production and/or enhances fibulin-5 activity, 
the other herbs present includes Psophocarpus tetragonolobus extract, phytic acid and 





4. ANTI-PARASITIC EFFECTS  
 TREATMENT OF  FASCIOLOSIS IN BUFFALOS 
Fasciolosis is an important helminth disease caused by two trematodes Fasciola hepatica (the 
common liver fluke) and Fasciola gigantica. 
(Maqbool et al, 2004) studied the anti-parasitic effects of Caesalpinia crista extract in the 
following study done on buffalos:- 
MATERIALS AND METHOD 
            One hundred and eighty buffalo were used in 18 controlled experiments to compare 
the efficacy of Caesalpinia crista seeds and certain other indigenous drugs, including 
Nigella sativa seeds, Fumaria parviflora aerial parts, and Saussurea lappa roots with 
triclabendazole against fasciolosis. Efficacy was quantified by determining the 
difference of eggs per g feces (EPG) pre- and post-treatment. Nigella saliva seeds, 
after a single dose of 30, 40 and 50 mg/kg body mass, reduced EPG by 54.16, 57.4 
and 58.33 per cent, respectively. After the second dose the respective reduction in 
EPG was 79.16, 80.85 and 81.25 per cent. Fumaria parviflora aerial parts at a rate of 
40, 50 and 60 mg/kg body mass were 50.0, 57.44 and 78.72 per cent, resp., whereas 
efficacy at two dose levels with the same dose rate was 82.6, 89.36 and 95.74 per cent, 
resp. Caesalpinia crista seeds at 30, 40 and 50 mg/kg body mass were 48.9, 50.0 and 
57.7 per cent effective, resp., whereas efficacy at two dose levels was 80.0, 84.09 and 
86.6 per cent, resp. Saussurea lappa at a rate of 50, 100 and 200 mg/kg body mass was 
46.6, 57.4 and 61.7 per cent effective, resp., at one dose level and was 62.2, 72.3 and 
78.7 per cent effective at two dose levels. Triclabendazole at one dose level at a rate of 
10 mg/kg body mass was 82.6 per cent effective and at two dose levels it was 95.7 per 
cent effective. The efficacy order was triclabendazole, Fumaria parviflora. 
Caesalpinia crista, Nigella saliva, and Saussurea lappa. No side effects were noted 
due to the use of any of these plant-origin drugs.  
 
This study demonstrates the Anthelmentic effect of Caesalpinia crista but the strongest effect, 




 ANTHELMENTIC EFFECT IN LIVESTOCK IN PAKISTAN 
(Javed, Akhtar et al. 1994) studied the Anthelmentic effects of Caesalpinia 
crista in the following comparative study with another Anthelmentic herb 
Chenopodium album. 
The aim of the study was to determine the Anthelmentic activity of Caesalpinia crista (L.) 
seed kernel and Chenopodium album (L.) (Chenopodiaceae) whole plant in order to justify 
their traditional use in veterinary medicine. 
Materials and methods 
 In vitro Anthelmentic activity of crude aqueous methanolic extract (AME) of both the plants 
was determined using 
mature Haemonchus contortus and their eggs in adult motility assay and egg hatch test, 
respectively. In vivo Anthelmentic activity was evaluated in sheep naturally infected with 
mixed species of gastrointestinal nematodes by administering crude powder (CP) and AME in 
increasing doses (1.0–3.0 g/kg). 
Results 
 Both plants exhibited dose- and time-dependent Anthelmentic effects by causing mortality of 
worms and inhibition of egg hatching. 
Caesalpinia crista (LC50 = 0.134 mg/ml) was found to be more potent than Chenopodium 
album (LC50 = 0.449 mg/ml) in egg hatch test.  
In vivo, maximum reduction in eggs per gram (EPG) of faeces was recorded as 93.9 and 
82.2% with Caesalpinia crista and Chenopodium album AME at 3.0 g/kg on day 13 and 5 
post-treatment, respectively. Levamisole (7.5 mg/kg), a standard Anthelmentic agent, showed 





 These data show that both Caesalpinia crista and Chenopodium album possess Anthelmentic 







The phytochemical analysis on the fixed oil extract from the seeds of Caesalpinia 
crista done by (Njoku, Okeke et al. 1999) revealed the presence of  
ANTI- NUTRITIONAL TOXINS 
  
- GOSSYPOL 
- CYANOGENIC GLYCOSIDES 
- CYCLOPROPANE 
- HYDORXY AND EPOXY FATTY ACIDS 
 
 DECREASE IN EGG PRODUCTION AND REDUCED EGG AND CHICKEN SIZE 
IN CHICKEN 
In the studies done on chicken; the Gossypol and Cyclopropane cause 
decrease in egg production, size and chicken weight 
(Bhide, et al.1976). 
 ANTIFERTILITY IN MICE AND RAT 
The mice and rat fed on the Caesalpinia crista meal showed antifertility 
effect. This antifertility effect could be attributed to the compounds like 
Gossypol and especially Cyclopropane fatty acids; which has been 
implicated as an antifertility factor (Egbo E.A, 1984). 
 
 Anti-fertility effects of Gossypol has been demonstrated by (Brocas, Rivera 
et al. 1997)during pharmacological study done on bulls.  
Gossypol; a polyphenolic yellow pigment is also present in cotton plants 
(Gossypium specie) have been implicated as a reproductive toxicant. 
 
In this study it was demonstrated that Gossypol (50 and 100 µg/ml) decreased the percentage 
of sperm, in bulls, that completed the swim-up procedure. This effect was not blocked by 
glutathione monoethyl ester. Cleavage rates were not different between oocytes inseminated 
with gossypol-treated spermatozoa (10 or 50 µg/ml) and oocytes inseminated with control 
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spermatozoa. Development to the blastocyst stage at Day 7 after insemination was reduced 
when spermatozoa treated with 50 µg/ml gossypol were used for fertilization. Gossypol 
toxicity was evident in cows fed cottonseed meal because erythrocyte fragility was greater 
than for control cows. However, there were no differences between cottonseed meal and 
control groups in number of oocytes collected per cow, cleavage rate after in vitro maturation 
and fertilization, or the proportion of oocytes or embryos that developed to blastocyst. 
Similarly, exposure of oocytes to 2.5-10 µg/ml gossypol during in vitro maturation 
did not affect cleavage rates or subsequent development. In contrast, addition of 10 µg/ml 
gossypol to embryos reduced cleavage rate. Moreover, development of cleaved embryos was 
reduced by culture with 5 or 10 µg/ml gossypol and tended to be reduced by 2.5 µg/ml 
gossypol.  
In conclusion, bovine gametes are resistant to gossypol at concentrations similar to those in 





 ANTI-MALARIAL ACTIVITY 
Malaria is one of the most life-threatening infectious diseases worldwide and 
claims the millions of people‘s life each year. The appearance of drug-
resistance Plasmodium falciparum has made the treatment of malaria 
increasingly problematic, and thus, it is a dire need to search the new 
alternatives of current drugs. 
Studies done by (Awale, Linn et al. 2006), (Kalauni, Awale et al. 2006),  
(Linn, Awale et al. 2005), on 44 cassane and Norcassane diterpenes shows 
the dose dependent anti-malarial effect, in invitro studies on plasmodium 
falciparum FCR-3/A2 clone, of the substances isolated from Caesalpinia 
crista extract including Caesalpinin K and norcaesalpinin F  showed IC 50 
values 120 nM and 140 nM respectively. 
But that most potent effect was seen with Norcaesalpinin E with IC50 
value 0.090µM is stronger than the clinical drug chloroquine having IC50 




These in vitro studies give scientific basis for the usage of; these guide 
lines could be used to design clinical trials in humans and efficacy could be 
tested for sub-types of malaria. And this herbal remedy which has been 
effectively used in Asia and Africa as a traditional antimalarial remedy 
could become a significant anti-malarial drug in the future and could 
effectively solve the resistance problems associated with the marketed 
drugs. 
 
 ACCELERATION OF FIBULIN-5 PRODUCTION/  ACTIVITY 
 
The work done by (Ogura, Amano et al. 2006) found the modulation of Fibulin-5 by a 
co-formulation including Caesalpinia crista and a few other plants; Fibulin-5 is a 
calcium dependent elastin-binding glycoprotein which participate in calcium signaling 
pathways (by binding to calcium) with their role in signal transduction. Calcium-
binding proteins contribute to all aspects of the cell‘s functioning from homeostasis to 
memory.  
Further Fibulin- 5 is and integrin-binding extracellular protein that mediates 
endothelial cell adhesion; also being a calcium dependent elastin-binding protein it 
scaffolds cells to elastic fibers, thereby preventing elastinopathy in the skin, lung and 
vasculature (Schiemann, Blobe et al. 2002).  
 
These facts could provide the scientific basis for usage of Caesalpinia crista as tonic 
herb in the traditional healthcare in Asia and Africa, and other effects like protection 
against elastinopathy, through modulation of fibulin-5. 
 
But the effect of Caesalpinia crista in this composition should be further studied as 





 TREATMENT OF LEKORRHAGIA 
The scientific work done by (Duan 2006) described an effective and long acting  anti-
leukorrhagic herbal remedy including Caesalpinia crista a number of other 
ingredients. This may scientifically support the traditional anti-leukorrhagic usage but 
it is further needed to search the active ingredient responsible for this effect. 
 ANTI-PARASITAL EFFECTS 
 
The study done by (Maqbool, Hayat et al. 2004) and (Javed, Akhtar et al. 1994) gives 
scientific basis for the traditional usage of Caesalpinia crista as Anthelmentic drug in 
Asia and Africa. However the effect is not stronger than that of Chenopodium album 
but weaker than the synthetic drug Triclabendazole and Levamisole.  
Research could be done to work on a combination formulation including 
triclabendazole or Levamisole and Caesalpinia crista and/ or other herbs proved 
useful Anthelmentic to design a formulation which could reduce side effects related to 
monotherapy alone with the synthetic substances. 
 
By using these guidelines after successful usage in animals Caesalpinia crista could 
also be clinically tested on humans and may provide a significant effective and cost 
effective alternative to the presently marketed anti-parasital drugs and could meet the 
challenges of resistance to the clinical drugs in use. 
 
 CHEMICAL STUDIES ON FIXED OIL FROM Caesalpinia crista 
The chemical studies done on the fixed oil obtained from Caesalpinia crista showed 
little nutritional value but it could be employed as a local cheap source of industrial oil 
and could substitute many industrial processes, could be employed in the cosmetics 
industry, considering some components of the oil especially the vitamins and lecithin 
present. 
 GOSSYPOL A MALE CONTRACEPTIVE AGENT 
The study done by (Brocas, Rivera et al. 1997)demonstrates that at concentrations 
above 10µg/ ml gossypol caused a concentration-dependent decrease in the percentage 
of sperm successfully completing the swim-up procedure as compared to sperm 
without gossypol. Both 50 µg/ml and 100µg/ ml reduced the proportion of sperm 
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motility hence reduced the proportion completing the swim-up procedure indicating 
gossypol induced failure to fertilize. 
Further addition of 10µg/ ml gossypol after fertilization caused a reduction in cleavage 
rate leading to reduced development of embryo. 
 
(Ji 2008) has invented a method of production of gossypol acetate; a mile stone 
towards production of herbal contraceptives for males. 
 
These facts give scientific basis for traditional usage of Caesalpinia crista as male 
contraceptive and Abortifacient. It is a significant finding since there is not available 
any synthetic male contraceptive in the market. Further research could be done to 
design a safe and effective herbal male contraceptive. 
 
      Further (Wang, Li et al. 2006)demonstrated in a pharmacological in vitro study that    
gossypol could induce differentiation in the leukemia HL-60 cells, and it may be a potential 
therapeutic agent, chemoprevention or chemotherapeutic adjuvant especially in combination 




A lot of other traditional usages in Asia and Africa need to be proven by scientific and 
clinical work. Further the efficacy during pregnancy looks risky due presence of anti 
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BOTANICAL NAME: - smilax ornata ( Lem) 
 ENGLISH NAME: - sarsaparilla 
URDU/ LOCAL NAME: - Ashba 
FAMILY: - Smilacaceae 
 
INTRODUCTION 
A number of plants in genus smilax are called sarsaparilla including smilax ornata, smilax 
regelii, smilax sarsaparilla etc; in this literature search emphasis is given to smilax ornata but 
a few other species known as sarsaparilla, having significant traditional medicinal usage, have 
also been described.  
PARTS OF PLANT USED: - Dried root and rhizome. 
 
ETHNOPHARMACOLOGY 
USES IN PAKISTAN 
1. Rheumatism 
2. Gout 
3. Skin disorders  
 Eczema 
 Psoriasis 
USES IN MORROCO 
Treatment of Leprosy. 
HEALTH SUPPLIMENT USED IN USA 
(Hastings, Barnes et al. 2001) describes a health supplement, in which sarsaparilla 
root is present as 10.75%, along with other herbs, for healthy joints. 
CHEMISTRY  




ISOLATON OF ESSENTIAL OIL (Power and Salway 1914) 
 
For the purpose of complete chemical examination 22.1 Kilograms of the ground 
material were extracted by continuous percolation with hot alcohol. After the removal 
of greater portion of the alcohol, a viscid, dark-colored extract was obtained, 
amounting to 2.95 kilogram. 
The whole of above extract was mixed with water, and a vigorous current of steam 
passed through the mixture for several hours. The distillate, on extraction with ether, 
yielded 2.6 gram of an essential oil. Being thus equivalent to about 0.01 percent of the 
weight of root employed. This essential oil, when distilled under diminished pressure, 
passed over between 70 and 200◦/15 mm. as a pale yellow liquid, which possessed a 
pleasant, somewhat aromatic odor, a density of 0.977 at 15◦/15◦, and was not 
completely soluble in 70 percent alcohol. It was found to contain furanalaldehyde, and 
also gave a bluish-black color with ferric chloride, thus indicating the presence of a 
phenolic substance. 
ISOLATION OF RESINS 
After above operation the steam distillation flask contained a considerable quantity of 
a brown resin, which formed with the aqueous liquid a viscous emulsion. 
Since the resin did not separate on keeping, the mixture was agitated wit hot amyl 
alcohol. By this means a very dark-colored aqueous liquid (A) was obtained, whilst 
the amyl-alcoholic extract contained the resin (B), partly in solution and partly in 
suspension. The extract was filtered, the filtrate well washed with water, the solvent 
then removed, and the residual semi-solid resin, together with that portion which was 
insoluble in amyl alcohol was separated. 
Resin separated is composed of following:- 
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 Sitosterol(C27 H46O) 
 Sitosterol-d-glucoside(Phytosterolin), C33H56O6 
 
The following are main substances obtained from Sarsaparilla root extract. 
 
1. Parillin (C26H44O10, 2 ½ H2O) Crystalline and almost insoluble in cold water. 
 
2. Sarsaponin (C45H74O17), a crystalline solid, isolated from the alcoholic solution of 
resin. 
Readily soluble in water, it has melting point 230-240 degree centigrade (Van Der 
Haar, 1929). And formula, on hydrolysis it yields one molecule of Sarsapogenin 
(Parigenin), two molecules of glucose and one molecule of rhamnose. 
 
Sarsapogenin is chemically classified as ―Digitalis glycosides‖, should not be 
confused with cardiac glycosides which is a different chemical group having different 
chemical functions. In addition Sarsapogenin has no pharmacological action on 
cardiac muscles. A still further differentiation lies ability of digitalis saponins to 
hemolyze erythrocytes. Furthermore the standardization of this Sarsaponin compound 
by the hemolytic index serves completely to control optimal quality, uniformity and 
composition. 
3. Sarsapogenin (C26 H42 O3), obtained by hydrolysis of Sarsaponin. 
4. Sarsapic acid (C6H4O6), it is isolated from the aqueous liquid (A). It is soluble in 
alcohol, sparingly soluble in cold water and ether. 
5. Smilasaponin (C20H32O10)5,12H2O, Amorphous and soluble in water. 
6. Smilacin(Smilasaponin) 
7. Smilagenin 
8. Steroidal saponins 
9. Fatty acids 
10. Phytosterol( isolated from resinous residue) 
11. Starch 
12. Minerals( Potassium) ( British Herbal Compendium, 1992). 
ENZYMES (Power and Salway 1914) 
In the following test described in ―The British pharmacopoeia‖ it was confirmed that 
sarsaparilla extract contain enzymes. 
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500 g of powdered sarsaparilla root was mixed with water and kept for two days at 
ordinary temperature. The mixture was then filtered under pressure, and alcohol added 
to the filtrate. A flocculent precipitate was thus produced. Which when dried in 
vacuum over sulphuric acid, amounted 2.6 gram or 0.52% of the weight of root 
employed. This substance slowly hydrolyzed amygdaline, thus indicating its enzymic 
activity. 
Sarsaparilla has been erroneously touted to contain testosterone and/or other anabolic 
steroids. While it is a rich source of steroidal saponins, it has never been proven to 







(Ageel et al, 1989) researched on sarsaparilla and a six other plants, being used in 
Saudi Arabia for their anti-inflammatory effects in Carrageenan-induced acute 
inflammation in rats. The plant materials were extracted with 96% ethanol. The dried 
extract was dissolved in water for pharmacological testing. The rats were administered 
an oral dose of 500mg/kg body weight of each extract 1 hour before production of 
inflammation by Carrageenan injection.  
The paw volume was measured at 0, 2, 3 and 4 hours the injection. 
Sarsaparilla (25 %) and three other plants out of seven plants inhibited Carrageenan 
induced acute inflammation. sarsaparilla also inhibited cotton pellet induced 
exudation. According to this study sarsaparilla has 25 % anti-inflammatory activity 
which is a significant effect. 
 
 
2. TONIC EFFECTS 
Sarsaparilla has been traditionally used as tonic; it improves tone, vigor and function 
of a particular body organ or body system. It has also been used as male tonic and it is 





1. TRETMENT OF SKIN DIORDERS/PSORIASIS 
BAKGROUND 
(Ransom. 1901), in an out –moded way, demonstrated a chemical affinity between the 
saponins and serum cholesterin by which the saponins acted on tissues without 
causing haemolysis. 
 
A few researchers believed that psoriasis is related to higher cholesterol/ lipid in the 
blood and described that disturbance in the metabolism of lipids to be the cause but 
these arguments were countered by opposite observations relating lower cholesterol to 
be the cause of psoriasis. 
 
(Madden et al, 1939) using cholesterol-tolerance tests, observed that 
hypercholesteremia tests, observed that hypercholesteremia did not generally exist but 
a lower fat diet was of definite value in 68 % cases tested for psoriasis. Madden, s 
patients were hospitalized. He inclined to believe that favorable effect of diet might be 
explained on the basis of general alignment of metabolism, rather than correction of 
disturbed fat metabolism and sarsaparilla because of its saponins contents has 
especial affinity for glucose. 
 
Despite these conflicting findings Wise and Sulzberger, 1940 state that there is no 
doubt that certain cases of psoriasis are much improved by a strict ―fatless‖ diet.   
 
 
USAGE OF SARSAPARILLA FOR PSORIASIS 
(Philippsohn 13) studied effectiveness of sarsaparilla extract leading to gradual relief 
in psoriasis. A no. of patients, under this study, took 1000cc of taped water, took 15 
gram sarsaparilla in it and allowed the mixture to stand overnight, and then boiled for 
twenty minutes next morning. While the mixture was still hot they drunk half of that 




(Ritter 14) studied a clinical trial in which 19 private patients were given 10 tablets 
each daily. Nine patients became completely or nearly completely free from psoriasis. 
The shortest required duration of treatment was two weeks. 
 
CLINICAL TRIAL DONE BY (THURMON, 1942) 
 
In these clinical trials, covering two years, 92 patients were studied. Of these 75 
patients of psoriasis were treated with sarsaparilla tablets and 17 served as controls 





1 tablet twice daily, preferably taken with warm liquid, when empty stomach. 
A larger dose comprising of two tablets twice daily or even tow tablets morning and 
evening and one at noon. 
 
Children:- 
Children aged 5 years or under, half a scored tablet given twice daily is sufficient. 
 
Local treatment 
            The 75 treated patients did not get any local treatment in the first 12 months. After 12 
months it was determined that sarsaparilla has given relief. Afterwards local treatment with 
irradiation in the form of sunshine or ultraviolet lamp, boric acid ointment , lanolin petroleum, 






62 percent of the treated patients gave good results to treatment. 14 percent became 
clearly well from psoriasis including a patient who has been sick of psoriasis for the 
last 18 years. 
2. TREATMENT OF LEPROSY 
(Leprosy) 
The Norwegian doctor Gerhard Armauer Hansen identified the etiologic agent, 
Mycobacterium leprae, which causes the infectious disease leprosy or Hansen‘s disease that 
affect mainly the peripheral nerves of the human being skin. 
 
(Rollier 1959) clinically demonstrated effect of leprosy, by a clinical study in combination 
with a synthetic anti-leprotic drug called DDS (4, 4-diaminodiphenylsulfone); pathologies of 
nasal mucosa and lepromas were measured to find out the clinical effect.  
 
Material and methods 
1. Weak aqueous extracts of smilax ornata  
2. Tablets containing 240 mg of the extracts. 
 
The leprosy effected patients were divided to two major groups; the first one receiving a 
combination treatment with Smilax ornata and DDS (4, 4-diaminodiphenylsulfone) {DDS-
smilax} and the second one only DDS as a monotherapy to serve as control.  
It is notable that all cases had positive skin lesions, but that several in each group gave 
negative nasal smears. It was impossible to make the groups strictly comparable, and the 
DDS-smilax group had slightly greater degree of positivity, which makes the findings more 
significant.  
 




The DDS was given in progressive doses, starting at 25 mg and increasing by 25 mg every 3 
weeks, never exceeding a daily dose of 150 mg for adults weighing 70 kg. 
 
 The sarsaparilla dosage was increased from 4 to10 tablets in the first week, remaining at the 
daily dose of 10 tablets for a minimum period of 6 months and a maximum of 1 year. 
Subsequently, the treatment was continued with DDS alone in the classical dose of 150 mg 
per day for adults. 
 
The bacteriologic, clinical and biological results , supported to some extent by pathologic 
findings, have been compared with those obtained with DDS alone in a comparable lot of 140 
patients, distributed as follows: 42 L1 (30%), 56 L2(40%), 38 L3(27%), and 4 regressive 
(3%). The patients of this second group were given the same doses of DDS as those in the 
first group. With both groups the treatment was given 6 days a week. 
 
BACTERIOLOGIC CHANGES IN NASAL MUCOSA 
The degree of bacteriologic passivity in the two groups, group 1 on the combination treatment 
and group 2 on DDS alone, in the nasal mucosa are given below in the table. 
 
Degree of bacteriological positivity in percentages, before, during and after treatment, of 









Negative 1+ 2+ 3+ 4+ 
Before 0a 14 34 42 10 
After 6 
months 
54 29 13 4 0 
After 1 year 83 9 8 0 0 
After 1 ½ 
year 
93 7 0 0 0 
After 2 year 100 0 0 0 0 
After 2 ½ 
year 
100 0 0 0 0 
 
a of  the 111 cases in Group 1 , only 100 were positive in the nasal mucosa before treatment, 
and they are taken as 100 percent in this table. 
 




Negative 1+ 2+ 3+ 4+ 
Before 0b 22 33 35 10 
After 6 
months 
27 34 29 10 0 
After 1 year 52 37 8 3 0 
After 1 ½ 
year 
74 21 4 1 0 
After 2 year 86 12 2 0 0 
After 2 ½ 
year 
98 2 0 0 0 
 





With respect to the changes under treatment, considering first the cases positive in the nose 
(100 of the 111 in the combined-treatment group and 120 of the 140 in the DDS control 
group), 54 percent of the first group became negative within 6 months, and 83 percent within 
a year; whereas of the second group only 25 % had become negative after 6 months and 52 
percent in a year. The nasal smears of all the patients in the experimental group were negative 
by the end of 2 years and those of control group in 3 years. 
BACTERIOLOGIC CHANGES IN LEPROMAS 
 
Degree of bacteriological positivity in percentages, before, during and after treatment of 
Group 1 (DDS-smilax, 111cases) and Group 2 (DDS control, 140 cases), in the lepromas. 
 
Group 1 (DDS-smilax group, 111 cases) 
Period of 
treatment 
Negative 1+ 2+ 3+ 4+ 
Before 0c 6 16 50 28 
After 6 
months 
13 23 30 32 2 
After 1 year 24 22 32 22 0 
After 1 ½ 
year 
37 27 29 7 0 
After 2 year 51 41 10 0 0 
After 2 ½ 
year 
57 32 11 0 0 
After 3 years 61 33 6 0 0 
 








Negative 1+ 2+ 3+ 4+ 
Before 0c 16 31 32 22 
After 6 
months 
4 30 32 28 6 
After 1 year 8 48 29 11 4 
After 1 ½ 
year 
22 51 21 5 1 
After 2 year 41 42 13 4 0 
After 2 ½ 
year 
57 31 11 1 0 
After 3 years 61 27 12 0 0 
 
c All the cases were positive in lepromas. 
 
All the patients were positive to lepromas and were biopsied routinely before treatment and 
simultaneously several punctures were made. These punctures and biopsies were repeated 
every month for 6 months and every 6 months thereafter. The same person took the biopsy 
specimens and made the smears and the same physician interpreted the microscopic findings, 









The above  tables shows significance of combined treatment with (DDS-smilax); having 
greater effect as all the patients getting rid of nasal smears within 2 years as compared to 
control group.  
After 6 months 13 percent of Group 1(DDS-smilax group) became leproma fri as compared to 
only 4 percent in Group II (DDS alone, control group). Also no patient showed highest 
positivity 4+ within a year from Group 1 but there was still 4 percent in the Group II having 
highest bacteriologicity at the end of one year.  
 
These findings prove that the effect of sarsaparilla is unquestionable. Its effects persisted 
even after the cessation of its administration; since it was not until the end of the third year of 
treatment that a lot of patients who received DDS alone come up to the same level of 






There are not reported toxicological studies done on sarsaparilla in the authentic scientific 
literature. 
 
Two women used sarsaparilla tablets during pregnancy got significant effect for psoriasis 
without any harmful effects on fetus (Thurmon, 1942). 
(Philippsohn13) did not noticed untoward effects from sarsaparilla; one patient who has used 







 ANTI-INFLAMMATORY ACTIVITY 
(Ageel et al, 1989) demonstrated anti-inflammatory effect of sarsaparilla in 
pharmacological studies in rats; these findings could be used to design clinical trials in 
humans. The traditional usage for years has already proved it safe and effective. This 
study gives scientific basis, for traditional usage of sarsaparilla as  
Anti-inflammatory herb, in the treatment of rheumatism and gout, in Pakistan and use 
in USA as a part of health food supplement (Hasting et al, 2001). 
These findings open for further research to find out the active ingredients having anti-
inflammatory effect and may lead to good herbal alternative, which could be used 
either alone or in combination with synthetic substances, to reduce a lot of serious side 
effects related with synthetic NSAIDs. 
 
  ANTI-LEPROTIC TREATMENT 
With the advent of modern medication with mullet drug therapy for leprosy; this disease is 
vanishing slowly vanishing. But we can meet it principally in the tropical zone countries. 
Brazil has the second greatest number of leprosy cases around the world with almost 30,000 
new cases diagnosed in 2005(Jose M et al, 2007). 
 
The studies done by (Rollier 1959) gave scientific/ epidemiologic prove for the efficacy of 
Smilax ornata being used by the Moroccans in the traditional settings. It gives considerable 
interest in the mixed treatment, for endemic areas where it is technically impossible to 
hospitalize systematically all open cases. 
A combination of Smilax ornata and synthetic drugs could be even more effective treatment 
which helps to overcome the problem of drug resistance. 
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 TREATMENT OF PSORIASIS 
A new drug, the water soluble saponins, called ―Sarsaponin, obtained from 
Honduras Sarsaparilla is described in the study done by (Thurmon et al, 1942). It 
shows 62 percent got beneficial effect of oral treatment with sarsaparilla. 
14 percent gave complete relief from psoriasis. These facts support the traditional 
usage of sarsaparilla for the treatment of psoriasis, however the exact mechanism 
of actions has not yet been determined and there is need for further research to find 
out the active ingredient. Also combined therapeutic approaches could be 
employed including local treatments to get the best results. This study gives 
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BOTANICAL NAME: - Styrax benzoin (Dryand) 
ENGLISH NAME: - Benzoin (USP 2008 p.1506) 
URDU/ LOCAL NAME: - LOBAN 
FAMILY: - Styracea 
 
 
PARTS OF PLANT USED:- 
Incised stem exudates. 
 
DESCRIPTION 
Benzoin obtained from Styrax benzoin  is composed of blocks or lumps of  varying size, made 
up of tears, compacted together, with a reddish brown , reddish gray , or grayish brown 
resinous mass. The tears are externally yellowish or rusty brown, milky white on fresh 
fracture; hard and brittle at ordinary temperature but softened by heat and becoming plastic on 
chewing (USP 2008 p. 1506-07). 
 PRODUCTION OF BENZOIN 
(Reinitzer 1926) described the production of Styrax benzoin.  
Stems of the vigorous and healthy trees are incised and hammered at cambium level to 
obtain better flow of resin. The resin that first appears is amorphous, unsightly and 
therefore rejected of no value. Later a crystalline milk-white resin exudes which is 
collected. Collection is effected every 3rd month, first   by removal of a bark-free 
layer, later a darker layer containing some bark and finally one dark and grossly 
contaminated layer. These 3 sorts are brought to the native towns in Sumatra and are 







USES IN PAKISTAN 




 USES IN THE PHARMACEUTICAL INDUSTRY 
Resinous material obtained from Styrax benzoin can be used to formulate incompatible 
vitamins, minerals and dietary supplements in the same tablets by coating around individual 
components. The coating can be done by dissolving the resinous material in an organic 
solvent and thoroughly mixing the concerned material in it followed by evaporation 
(Anderson 1946). 
 Adhesive to surgical instruments 
 USED AS FIXATIVE IN PERFUMARY 
Gum benzoin can be used as fixative in perfumery, slows down dispersion of perfume 
particles (Boelens, De Rijke et al. 1982). 
 Used in cosmetics and pharmaceutical colorless nail lacquer, nail lacquer bases and 
nail hardener compositions containing alcohol, shellac and benzoin oil Wohnhas 
(2002) 
 USAGE AGAINST TINNITUS 
(Joan scurlock et al p.7) described the usage of Styrax benzoin against tinnitus by the ancient 
Babylonian physicians, as described in the old manuscripts. 
 CO-INGREDIENT IN A FORMULATION AGAINST ENVIRONMENTAL POLLUTION 
CAUSED DISEASES 
Styrax benzoin has been used in an Ayurvedic preparation along with other ingredients 





• Identification test:- 
A solution in alcohol becomes milky upon the addition of water, and the mixture is acid to 
litmus paper (USP 2008 Vol II P.1507). 
• Chemical composition:- 
●Benzoin resin (a water insoluble resin) also commonly known as Sumatra benzoin or 
gum benzoin or gum Benjamin, this is mainly composed of balsamic acids i.e Benzoic 
acid.  
●Free benzoic acids and cinnamic acids 
●Esters of benzoic and cinnamic acids with coniferyl and p-coumaryl alcohols f.eks. 
Coniferyl benzoate. 
●    Pinoresinol 
 
Different qualities of gum resin obtained from Styrax benzoin can be classified into six 
different classes based on color and particle sizes and method of harvesting. The first 
two classes are harvested from the stem under bark and are lighter in color and the 
remaining classes are harvested from the stem outside the bark and are darker in color; 
class sixth is the darkest one. Dark color is due to reaction with light for several days 
(I. Pastorova 1997). 
 
 
           Figure on next page:-Components identified in the gum benzoin resins 
from Styrax paralleloneurum Perk and from Styrax benzoin Dryand (Pastorova, de 







● Compounds identified by GC–MS and quantified by GC–FID in gum benzoin 
resins from Styrax benzoin percentage composition 
a
(Pastorova, de Koster et al. 1997). 
Name 
compound b 
Class c Rn d Ist e 3
rd
 e Mix e 
 Benzoic 
acid 
A 1 19.2 28.2 46.9 
Cinnamic 
acid 
B 0.94 1.8 7.5 40.4 
Cinnamyl 
benzoate 
C 0.74 0 0.5 0.5 
Benzyl 
cinnamate 
D 0.72 0 0 0 
Cinnamyl 
cinnamate 
D 0.72 0 0 0 
p-coumaryl 
benzoate 
C 0.86 52.5 30.5 0 
Coniferyl 
benzoate 
C 1.8 18.2 15.6 0 
p-coumaryl 
cinnamate 
D 0.83 1 1.1 0 
Coniferyl 
cinnamate 
D 0.9 0 0 0 
Pinoresinol F 0.86 4.1 10.8 6.1 
Benzoic acid 
ester 
F 0.88 1.1 1.4 0.6 
Benzoic acid 
ester 
F 0.88 1.3 2 0.6 
Triterpene E 0.78 1.3 3.1 2.3 
Cinnamic 
acid ester 
F 0.87 0 0 0 
 
a
Only compounds with a relative amount of more than 0.5% (normalized to 




cA—free benzoic acid; B—free cinnamic acid; C—benzoic acid esters;  
D—cinnamic acid esters; E—Triterpene; F—Pinoresinol and high molecular 
Weight aromatic esters. 
Rn d —relative molar response factor. 
eQuality of resin tested: 1st—first quality; 3rd—third quality; Mix—a mixture 
of third, fourth and fifth qualities. 
BIOLOGY/ PHARMACOLOGY 
 
1. STYRAX BENZOIN AGAINST OSTEOPOROSIS 
 
Styrax benzoin extract is a calcium absorption acceleration activator and can be used 
both to prevent and cure bone diseases due to deficiency of Calcium like osteoporosis 
(Nomura, Murase et al. 2008). 
Preparation of a gum benzoin extract involves:- Resin 10g of gum benzoin , 50% 
ethanol 100mL was added, left for seven days, after settlement extraction, it was 
filtered and extract, 92mL, was obtained at room temperature (Nomura, Murase et al. 
2008). 
 
2. ANTIALLERGIC ACTIVITY 
(Suzuki, Shimada et al. 2006) studied and described that Styrax benzoin lowers 
production of IL 4( Interleukin 4) by 58%, when used in a concentration of 33% 




3. MELANIN  FORMATION PROMOTER ACTIVITY IN A  
CO-FORMULATION 
 
(Suzuki, Umishio et al. 2002) invented a formulation comprising of various extracts of 
plants including Styrax benzoin to prevent gray hair. The mechanism of action is to 
improve cAMP (Cyclic Adenosine monophophate) of the melanocytes which leads to 
increased melanin production, a decrease in white melanism and tanning effect. As a 
result prevention of grey hairs is achieved. 
 
4. SKIN WHITENING EFFECT 
According to (Tanaka 2006) Styrax benzoin along with other ingredients inhibits 
phagocytosis of melanosomes by keratinocytes in the skin epidermis thus inhibiting 
the transport of melanin, produced by melanosomes, to skin epidermis thus giving the 
skin a brighter color. 
The substituting method which induces phagocytosis using false melanosomes, such 






1. Benzoin can cause skin sensitization (Martindale 33rd edition page 1668). 






> ANTISEPTIC USAGE 
● The overuse, misuse and prophylaxis to the microbes making resistance being the major 
problem in the health care setting of antiseptics are gaining renewed interest due to having 
lower propensity for resistance instead of the matter of fact that antiseptics could be more 
lethal to mammalian cells as compared to the traditional antibiotics. Molecular iodine and 
silver are broad-spectrum antimicrobial agents that encourage healing in the microbially 
compromised wounds. New compounds inhibiting microorganisms like benzoin (Styrax 
benzoin) and emetine has been isolated from plants 
(Muthusamy S K et al p. 94-95). 
 
 
● Sumatra benzoin is used in topical preparations for its antiseptic and protective 
properties (Martindale 33
rd
 edition p. 1668) 
 
The following formulations for topical usage are available:- 
--- (BP 2001) Compound Benzoin tincture (Frisar, s Balsam) 
--- (BPC 1954) Compound Benzoin Tincture 
---U8SP 2008 vole II) Compound Benzoin tincture 
 
● Facts about antimicrobial activity of benzoin described by  
(Muthusamy et al, 2008)  
 
The antiseptic usage of Benzoin obtained from Styrax benzoin as described above in 
the authentic scientific literature gives scientific evidence for antiseptic usage in 






> RESPIRATORY CATARRH (EXPECTORANT) 
 ● Sumatra benzoin obtained from Styrax benzoin is an ingredient of inhalations which are 
used in the treatment of the upper respiratory tract catarrh (Martindale 33rd edition) 
Preparations available in (BP 1998), Benzoin inhalation. 
Usage of Styrax benzoin   against respiratory catarrh as described above in (BP 1998) and 
(Martindale 33
rd
 edition) scientifically attests the traditional usage of Styrax benzoin for 
Respiratory Catarrh in Pakistan. 
 USAGE AS CALCIUM ABSORPTION ACCELERATOR 
 
Styrax benzoin extract acts as a calcium absorption accelerator by active transport 
process in the small intestine, it increases the gene expression of calcium- transporter 
protein Ca T1 (by manifesting mRNA) 
(Nomura, Murase et al. 2008). 
 
This discovery could be used to develop oral drinks, tablets or other types of 
formulations by using suitable ingredients. 
 
Besides, gum benzoin or its extract, calcium preparations, such as calcium carbonate 
and a calcium chloride, DFAIII (twin TOSU), FOS (fructo oligosaccharide), CPP 
(casein phosphopeptide), Citrate malic acid calcium, vitamin D, a vitamin K, soy 
isoflavone, collagen, etc. can be blended suitably if needed, and improvement in 
calcium ingestion and bone strength can be aimed at (Nomura, Murase et al. 2008). 
 
 
The above findings could be a milestone to find alternatives to the modern treatment 
of bone diseases like osteoporosis, it could also be researched to combine both modern 
treatments available and benzoin formulation to get best effect and reduce frequency 




 USAGE FOR TINNITUS 
Scurlock et al, year, described the anti Tinnitus usage of Styrax benzoin by the ancient 
Babylonian physicians (Babylonians was an ancient civilization many thousands of 
years ago).  
The Babylonian physicians advised the persons sick of Tinnitus to Wrap Resin 
(Benzoin resin) in Arantu grass and kukru in a tuft of wool and put it down in water 
and boil over fire. Then to drop the extract in ears cavity 
. 
 
This description in the old manuscripts could be a starting point for the scientists 
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BOTANICAL NAME: - Crocus sativus (L) 
FAMILY: - Iridaceae 
ENGLISH NAME: - Saffron 
URDU NAME: - Zafran, Kesar 
 
INTRODUCTION 
The origin of saffron is obscure, but the plant is believed to have originated in 
the eastern Mediterranean, probably Asia Minor and Persia. The name ‗‗saffron‘‘ is 
derived from Arabic za´-faran ‗‗be yellow.‘‘ The spice was known to the Greeks as 
Krokos (as mentioned by Homer in the Iliad), but the name is pre-Greek and possibly 
of Babylonian-Assyrian origin  (Schormüller 1970). 
 
The chemical composition of saffron has been thoroughly studied and considerable 
Knowledge about volatile as well as non-volatile saffron constituents, their analysis, 
stability and generation has been accumulated within the last decades. Whereas initially most 
of the research activities were directed to the analysis and structural elucidation of saffron 
pigments, the focus in recent studies has shifted towards the characterization of the complex 
saffron flavor as well as toward questions regarding the generation of some of the key flavor 
compounds. In the course of the still ongoing search for phytochemicals with antitumor 
activity, saffron carotenoids were also tested for possible activity. In different in vitro studies, 
saffron carotenoids were found to be highly effective. They inhibited, for example, 
proliferation of a leukemic cell line. Such findings stimulated renewed interest in the possible 





PARTS OF THE PLANTS USED 
Dried flowers. 
Saffron is a spice derived from a flower of Crocus sativus, a species of family Iridaceae. The 
flower has three stigmas, which are the distal ends of the plant‘s carpels. Together with its 
style, the stalk connecting the stigmas to the rest of the plant, these components are often 
dried and used in cooking as a seasoning and coloring agent. For decades, saffron has been 




USES IN PAKISTAN:- 
1. FOOD: - (i) Saffron is a flavoring agent in sweets and other types of dishes. 
   Saffron has aromatic odor and has been used in food making since the ancient times 
(www.parc.gov.pk/data/medicinal/medsearch.asp). 
(ii) Saffron has been used as food color 
(www.parc.gov.pk/data/medicinal/medsearch.asp). 
 
 2.  MEDICINAL:-   
Saffron has following applications in the medical science in Pakistan 
 APHRODISIAC; In improving Sexual desire /erectile function e.g. 









3. CHEMICAL USES 
Saffron has been used chemically as:- 
a. Coloring agent 






USES IN EUROPE 
Saffron has a long history in European cuisine and today the spice is still used for 
Traditional fish and seafood dishes (Risotto alla Milanese in Italy, Bouillabaisse in 
France or Paella Valenciana in Spain). Saffron is a traditional ingredient in a few 
cakes, e.g., the German saffron cake ‗‗Gugelhupf.‘‘ Also the medicinal uses of saffron 
are diverse. Ancient Romans had hoped to benefit from its reputed ability to 
prevent hangovers by steeping the spice in their wine. Saffron has formerly being used as 




BIOLOGY OF SAFFRON 
Petals of Crocus sativus flower  are lilac to mauve and the outstanding feature of the flower is 







Saffron flowers are sterile, therefore the plant is not able to set viable seed and must be 
propagated vegetatively by the root tuber (G.A.Burdock 1995) (H.E.Laux 1996)  (W.Franke 
1989). 






Saffron is characterized by a bitter taste and an Iodoform or hay-like fragrance 
Caused by:- 
(i) Picrocrocin (Straubinger 2000). 
And aroma is due to:- 
(ii) Safranal  and 4-hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde (HO-
safranal) (Straubinger 2000). 
It also contains a carotenoids dye:- 
      (iii) Crocin which gives food a rich golden yellow hue (color)  (Straubinger 2000). 
VOLATILE COMPONENTS 
Saffron contains more than 150 volatile and aroma-yielding compounds including Safranal. 
For a long time, safranal (2, 6, 6-trimethyl-1, 3-cyclohexadiene-1-carboxaldehyde) was 
considered to be the character impact compound of saffron‘s aroma. Only recently have 
sensory studies revealed that additional trace constituents in the volatile fraction are equally 
important for the typical aroma of the spice 
(W.Rödel 1991) (K R. Cadwallader 1997). 
 
Quantitatively, safranal and its hydroxyl-derivative predominate in the 
aroma extract (47% and 13% of the total amount of volatiles, respectively). For both 
aldehydes (Zarghami and Heinz, 1971)assumed secondary formation via picrocrocin 
cleavage. 
 Next in concentration were compounds a (6%), b (6%), and c (3%). Each 
of the remaining volatiles was only present in a low concentration range of 0.3–2% 
of the total aroma fraction. 
a=4-hydroxy-3,5,5-trimethyl-2-cyclohexene-1-one. 
b=4-hydroxy-3-oxo-2,6,6-trimethyl-1,4-cyclohexadiene-1-carboxaldehyde. 






 Crocus sativus extract contain many nonvolatile active components (Abdullaev, 2002), many 
of which are carotenoids, including zeaxanthin, lycopene, and various α- and β-carotenes. 
However, saffron's golden yellow-orange color is primarily the result of α-crocin. This crocin 
is trans-crocetin di-(β-D-gentiobiosyl) ester (systematic (IUPAC) name: 8, 8-diapo-8, 8-
carotenoic acid). This means that the crocin underlying saffron's aroma is a digentiobiose 
ester of the carotenoid crocetin (Abdullaev, 2002). Crocins themselves are a series of 
hydrophilic carotenoids that are either monoglycosyl or diglycosyl polyene esters of crocetin 
(Abdullaev, 2002). Meanwhile, crocetin is a conjugated polyene dicarboxylic acid that is 
hydrophobic, and thus oil-soluble. When crocetin is esterified with two water-soluble 
gentiobioses (which are sugars), a product results that is itself water-soluble. The resultant α-
crocin is a carotenoid pigment that may comprise more than 10% of dry saffron's mass. The 
two esterified gentiobioses make α-crocin ideal for coloring water-based (non-fatty)  




The bitter glycoside picrocrocin is responsible for saffron‘s flavor. 
 (chemical formula: C16H26O7; systematic name: 4-(β-D-glucopyranosyloxy)-2, 6, 6- 
trimethylcyclohex-1-ene-1-carboxaldehyde) is a union of an aldehyde sub-element known as 
safranal (systematic name: 2, 6, 6-trimethylcyclohexa-1, 3-diene-1- carboxaldehyde) and a 
carbohydrate. It has insecticidal and pesticidal properties, and may comprise up to 4% of dry 
saffron. Significantly, picrocrocin is a truncated version (produced via oxidative cleavage) of 
the carotenoid zeaxanthin and is the glycoside of the terpene aldehyde safranal. The reddish-
colored
 
(Leffingwell, 2002) zeaxanthin is, incidentally, one of the carotenoids naturally 











When saffron is dried after its harvest, the heat, combined with enzymatic action, splits 
picrocrocin to yield D-glucose and a free safranal molecule (Abdullaev, 2002). Safranal, a 
volatile oil, gives saffron much of its distinctive aroma (McGee, 2004, p.423), (Dharmananda, 
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s. 2005). Safranal is less bitter than picrocrocin and may comprise up to 70% of dry saffron's 
volatile fraction in some samples (Leffingwell, 2002).
  
 A second element underlying saffron's aroma is 2-hydroxy-4, 4, 6-trimethyl-2, 5-
cyclohexadien-1-one, the scent of which has been described as "saffron, dried hay 
like"(Leffingwell, 2002, p.3). Chemists found this to be the most powerful contributor to 
saffron's fragrance despite its being present in a lesser quantity than safranal (Leffingwell, 
2002, p.3). Dry saffron is highly sensitive to fluctuating pH levels, and rapidly breaks down 
chemically in the presence of light and oxidizing agents. It must therefore be stored away in 
air-tight containers in order to minimize contact with atmospheric oxygen. Saffron is 
somewhat more resistant to heat. 
 β-D-glucopyranose derivative.                               Safranal moiety 
  
                 




















3. THE FORMATION OF CROCIN 
Crocetin                                                                                             ___ β-D-gentibiose 
                                                                                                          
___ β-D-gentibiose 
 (THE ESTERIFICATION REACTION BETWEEN CROCETIN AND 2 GENIBIOSE 
SUGAR MOLEDULES) 
 






Water-soluble components 53.0 
  →  Gums 10.0 
  →  Pentosans 8.0 
  →  Pectins 6.0 
  →  Starch 6.0 
  →  α–Crocin 2.0 
  →  Other carotenoids 1.0 
Lipids 12.0 
  →  Non-volatile oils 6.0 
  →  Volatile oils 1.0 
Protein 12.0 
Inorganic matter ("ash") 6.0 




Fiber (crude) 5.0 
   
 
5. Chemical composition 
of saffron 























1. ANTI-SPAMSODIC AND ANTI-DEPRESSIVE EFFECTS 
(Akhondzadeh, Tahmacebi-Pour et al. 2005) studied the anti-spasmodic effects of 
Crocus sativus in the following clinical study:- 
 AIM OF THE STUDY 
            This clinical study was done to assess the efficacy of the stigmas of Crocus sativus 
(saffron) in the treatment of mild to moderate depression in a 6-week double-blind, 
placebo-controlled and randomized trial. 
            MATERIALS AND METHODS 
            Forty adult outpatients who met the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition for major depression based on the structured clinical interview 
for DSM IV participated in the trial. Patients had a baseline Hamilton rating scale for 
depression score of at least 18. In this double-blind, placebo-controlled, single-centre 
and randomized trial. 
            DOSAGE 
            The patients were randomly assigned to receive a capsule of saffron 30 mg/ day (BD) 
(Group 1) or a capsule of placebo (BD) (Group 2) for a 6-week study. At 6 weeks, 
Crocus sativus produced a significantly better outcome on the Hamilton depression 
rating scale than the placebo (d.f. = 1, F = 18.89, p < 0.001). There were no significant 
differences in the two groups in terms of the observed side effects. 
            RESULTS 
            The results of this study indicate the efficacy of Crocus sativus in the treatment of 




2. PAIN RELIEVING(ANTI-NOCICEPTIVE) EFFECTS 
Nociceptive receptors are the receptors which send signals which cause pain 
perception, in response to pain stimuli.  
(Hosseinzadeh and Shariaty 2007) studied the pain relieving effects of a principle ― 
safranal‖ present in Crocus sativus extract in the following study done in mice:- 
MATERIALS AND METHODS 
 Safranal is one of the main constituents of saffron. In view of previous reports of anti-
nociceptive activity of saffron there was examined the anti-nociceptive property of 
safranal. Antinociceptive activity was determined using hot-plate, writhing and 
formalin tests in mice. Safranal at doses 0.1, 0.3 and 0.5 ml/kg/i.p. inhibited the 
abdominal constrictions induced by acetic acid and also at 0.5 mL/kg/i.p. increased the 
pain threshold of mice against the thermal source only at 30 min after treatment.  
            In formalin test, safranal at doses 0.05 mL/kg/i.p. significantly decreased pain-related 
behaviors in phase I and with lower dose (0.05 and 0.025 mL/kg/i.p.) phase II. 
Generally, naloxone (2 mg/kg, s.c.) did not abolished the anti-nociceptive effects of 
safranal completely.  
 
             RESULTS 
             The results showed that safranal have anti-nociceptive activity in chem. (formalin and 
acid acetic tests) methods and this effect may be medicated more peripherally. 
             ___________________________________________________________ 
 
            Naloxone=an opioid agonist. 
s.c= subcutaneous, ml= milliliter 




3. APHRODISIAC EFFECTS 
(Hosseinzadeh, Ziaee et al. 2008) demonstrated the aphrodisiac properties of saffron in the 
studies done on rats. 
 
MATERIALS AND METHODS 
In this study, the aphrodisiac activities of two major ingredients crocin and safranal present in 
Crocus sativus stigma aqueous extract and its constituents.  The aqueous extract (80, 160 and 
320mg/kg body weight), crocin (100, 200 and 400mg/kg body wt.), safranal (0.1, 0.2 and 
0.4ml/kg), sildenafil (60mg/kg body wt., as a positive control) and saline were administered 
intraperitoneally to male rats. Mounting frequency (MF), intromission frequency (IF), 
erection frequency (EF), mount latency (ML), intromission latency (IL) and ejaculation 




Crocin, at all doses, and the extract, especially at doses 160 and 320mg/kg body weight, 
increased MF, IF and EF behaviors and reduced EL, IL and ML parameters. Safranal did not 
show aphrodisiac effects. The present study reveals an aphrodisiac activity of saffron aqueous 
extract and its constituent crocin. 
 
 
4. ANTI-LEUKEMIC EFFECTS 
 
(Straubinger 2000) described the anti-leukemic effects of crocetin derivatives based on 
various anti-cancer studies. 
Carotenoid metabolites, especially the retinoids (i.e., vitamin A and derivatives), 
have attracted attention because of their possible anticarcinogenic properties. Although 
inhibition of growth of certain types of tumor cell lines was observed for retinoids, their level 
of toxicity precludes a general therapeutical application in humans. Contrary to retinoids and 
their parent compounds the carotenoids, saffron pigments exhibit a diapocarotenoid structure 
and, thus, crocetin derivates do not act as vitamin A precursor. According to the working 
hypothesis in studies on antitumor activity of crocetin derivatives reduced toxicity at higher 
doses in cancer chemotherapy was expected. Several in vitro studies with saffron pigments 
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have been carried out (42– 50). It is important to note that the mixture of the crocetin 
derivatives as well as the dicarboxylic acid crocetin and its methyl ester dimethyl crocetin 
were found to be highly effective in inhibiting the proliferation of a leukemic cell line. 
Concentrations that induced 50% inhibitions of cell growth were only slightly higher as 
observed for all-trans retinoid acid. Thus, saffron carotenoids are suggested as alternative 
antitumor agents, which alone or in combination with other chemical substances may have 
potential for the treatment of certain forms of cancer in the future. 
 
5. INSECICIDAL AND PESTICIDAL EFFECTS 
(Leffingwell, 2002) demonstrated that safranal; a principle isolated from Crocus 
sativus extract exhibits insecticidal and pesticidal effect. This fact could present 
Saffron as safe and effective herbal insecticide and pesticide which is more 
environment friendly than other synthetic insecticides and pesticides and may have 
potential to substitute the synthetic substances. 
TOXICOLOGY 
 
Saffron is toxic if taken in high doses. It has been used as abortifacient  by the traditional 
healers (Straubinger 2000). 
    Due to dose dependent abortifacient effect it should not be used by pregnant women and 







 ANTI-SPASMODIC EFFECTS 
(Akhondzadeh, Tahmacebi-Pour et al. 2005) demonstrated the anti-spasmodic effects 
of saffron in a double blind clinical trial by using 40 patients and proved efficacy of 
saffron as an herbal drug to treat mild to moderate depression. 
Depression is a serious disorder in today's society, with estimates of lifetime 
prevalence as high as 21% of the general population in some developed countries. 
Further research involving much larger patient population could uncover more details 
about the anti-depressive effects of saffron. However this clinical study gives 
scientific basis for safe and effective traditional usage of saffron for the treatment of 
depression. 
 PAIN RELIEVING EFFECT 
The pharmacological studies done by (Hosseinzadeh and Shariaty 2007) proves 
therapeutic efficacy of safranal isolated from Crocus sativus as a pain killer through 
inhibition of pain signaling through nociceptive receptors. The opioid agonist 
Naloxone did not inhibit the anti-nociceptive effect that is why this pain relieving 
effect is not mediated through opioid receptors but by inhibition of synthesis or action 
of prostaglandins. 
This scientific work scientifically supports the traditional usage of Crocus sativus as 
abdominal pain killer in Pakistan. 
 
 ANTI-LEUKEMIC EFFECTS 
The anti-leukemic effects described by (Straubinger 2000) gives anti-leukemic 
potential of saffron. Thus, saffron carotenoids are suggested to be alternative anti-
leukemic agents. Saffron could also be used as adjuvant to synthetic drugs to lower the 
side effects related to anti-leukemic therapy. 
 
However a number of other traditional uses including Emmenagogue and expectorat 
need to be verified by further scientific work. 
α-crocin is responsible for yellowish orange colour saffron gives during food 





Akhondzadeh, S., N. Tahmacebi-Pour, et al. (2005). "Crocus sativus L. in the treatment of 
mild to moderate depression: a double-blind, randomized and placebo-controlled trial." 
Phytother Res 19(2): 148-51. 
 
Abdullaev, FI (2002), "Cancer chemopreventive and tumoricidal properties of saffron (Crocus 
sativusL.)",Experimental Biology and Medicine 227 (1), 
<http://www.ebmonline.org/cgi/content/full/227/1/20>. Retrieved on January 10, 
2006. PMID 11788779. 
 
Dharmananda, S (2005), "Saffron: An Anti-Depressant Herb", Institute for Traditional 
Medicine, <http://www.itmonline.org/arts/saffron.htm>. Retrieved onJanuary 10,2006. 
 
G.A.Burdock, F. (1995). Handbook of Falvor Ingredients, CRC Press:Boca Raton. 
op. Rep. China). 7pp. 
 
H.E.Laux, H. L., A.Tode, Gewürzpflanzen, Franckh-kosmos, Stuttgart, 1996 (1996). 
 
Hosseinzadeh, H. and V. M. Shariaty (2007). "Anti-nociceptive effect of safranal, a 
constituent of Crocus sativus (saffron), in mice." Pharmacologyonline(2): 498-503. 
 
 
Hosseinzadeh, H., T. Ziaee, et al. (2008). "The effect of saffron, Crocus sativus stigma, 
extract and its constituents, safranal and crocin on sexual behaviors in normal male rats." 
Phytomedicine 15(6-7): 491-495. 
 
K R. Cadwallader, H. H. B., And M. Cai (1997). Spices-flavor Chemistry and antioxidant 
Properties, " ACS symp. ser. 660, (S.J. Risch and C.T. Ho, eds.): 66-79. 
 
Leffingwell, JC (2002), "Saffron", Leffingwell Reports 2 (5) p.1-3, 
<http://www.leffingwell.com/download/saffron.pdf>. Retrieved on January 10, 2006. 209  
 
McGee, H (2004), On Food and Cooking: The Science and Lore of the Kitchen p. 422-423, 
Scribner, ISBN 0-684-80001-2, <http://books.google.com/books?ie=UTF-
8&hl=en&id=iX05JaZXRz0C>. Retrieved onJanuary 10,2006. 
 
 
Schormüller, J. (1970). "Handbuch der Lebensmittelchemie."  Vol. VI. 
 
 
Straubinger, P. W. h. M. (2000). "Saffron-Renewed intrest in an ancient spice, Food Reviews 
International." Technische Universität Braunschweig, Braunschweig, Germany 16:1: 39-59. 
 
W.Franke, N., Thieme: Stuttgart, New York (1989). 
  
W.Rödel, M. P. a. (1991). High Res. Chromatography 14: 771-774. 
  














Since a lot of synthetic drugs are designed by using plants products as a mother molecule in 
one or other way. Also plants still contains a lot of valuable entities which could help to solve 
the mysteries of the modern therapeutics. That is why it is need of the hour to pay valuable 




In this work it could be concluded that a lot of scientific work is required to find the scientific 
basis of the traditional usages of plant products which has been safely used for hundreds of 
years. 
It could be concluded from this scientific work that the following plant remedies may change 
the future of modern therapeutics. 
 
1. Trigonella foenum-graecum 
(Shah, Bodhankar et al. 2006) studied that the active principles from the fenugreek leads to 
production of fresh β- cells of islets of langerhans and induction of hepatic enzymes involving 
carbohydrate metabolism in rat studies, the former effect is the unique one and could provide a 
better combination with hypoglycemic agents like Metformin. A lot of scientists working on 
fenugreek could give hope about a combination which could change the future of treatment of 
Diabetes type II. 
 
2. Carica papaya 
 
A principle obtained from Carica papaya ―papain‖ has been proved to be a marvelous 
anthelmentic agent, papain attacks the cuticle of worms and the generation of resistance to this 
effect is very slow (Stepek, Lowe et al. 2007) this effect make papain a very attractive in a lot 
of successful veterinary remedies. Further research is needed to be done.  
 
Carica papaya has been used both as a male and female contraceptive and abortifacient agent 
in females, in the traditional healthcare settings in Asia and Africa.  
Since we have not any male contraceptive available in the market, further work on positive 
findings in male rat studies done by (Lohiya Nirmal, Manivannan et al. 2006) could lead to 
synthesis of a safe and effective male contraceptive. 
 
3. Cassia fistula 
 
(Ammal, George et al. 2007) found, in the laboratory tests, that Cassia fistula extract changes 
the morphology of the cholesterol crystals, from plate like to needle like, deposited the 
atherosclerotic patches. It could be an adjuvant to the treatment of coronary diseases. Further 
work should be done to prove it clinically. 
  
A lot of other effects done by these useful traditional remedies like the effect of Citrullus 
colocynthis as anthelmentic in veterinary medicines, estrogenic effects of Dioscorea 
floribunda, anti spasmodic and anti-hypertensive effects of Ferula asafetida,  anti- parasitic/ 
anti-malarial effects done by Caesalpinia crista, and anti-psoriatic effects done by Smilax 
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ornata, and acceleration of uptake of calcium in the osteoporotic patients by Styrax benzoin 
extract should be further clinically studied to find safe effective and  much better therapeutic 
agents and lower the frequency of potential side effects.  
 
 
